Presbycusis

H8_HL_PRESBY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H91.1 Hospital discharge: ICD-9 — 3880 Hospital discharge: excluded ICD-9 — 2880X Cause of death: ICD-10 — H91.1 Cause of death: ICD-9 — 3880 Cause of death: excluded ICD-9 — 2880X 2 out of 7 registries used, show all original rules.	6544
4. Check minimum number of events None	6544
5. Include endpoints None	6544
6. Filter based on genotype QC (FinnGen only)	6361

Control definitions (FinnGen only)

Control exclude: H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H91
Name in latin: Presbyacusis

NAME	H8_HL_PRESBY
CONTROL_EXCLUDE	H8_OTHEREAR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H911
HD_ICD_9	3880
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL	2880X
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H911
COD_ICD_9	3880
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL	2880X
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Presbycusis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	64425	38004	26033
Only index persons	55412	33250	22162
Unadjusted period prevalence (%)
Whole population	0.94	1.09	0.73
Only index persons	1.07	1.22	0.85
Median age at first event (years)
Whole population	80.01	81.05	78.51
Only index persons	79.56	80.63	77.95

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6361	2996	3365
Unadjusted period prevalence (%)	1.32	1.06	1.54
Median age at first event (years)	76.95	77.08	76.83

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6543: Matched controls
64802

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

65.7

307.7

212

H91.1

ICD-10 Finland

Presbycusis

4503599627370496.0

307.7

6537

1314

DFF00

NOMESCO Finland

Pure tone audiometry

19.7

307.7

1539

997

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

128.1

307.7

3131

461

H91.9

ICD-10 Finland

Hearing loss, unspecified

10.3

307.7

619

653

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

5.6

307.7

1450

3154

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

8.6

307.7

444

543

H13

ICPC

Plugged feeling ear

3.3

307.7

2022

7747

DFF15

NOMESCO Finland

Speech audiometry

17.8

307.7

800

502

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

115.2

307.7

181

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

3.8

307.7

2351

8354

SPAT1043

SPAT

Audiometry

7.7

307.7

1602

2612

H02

ICPC

Hearing complaint

6.8

307.7

2090

4191

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

22.2

307.7

512

247

DAX08

NOMESCO Finland

Fitting of hearing aid

34.3

307.7

1063

364

R5140

NOMESCO Finland

Monitoring the use of the aid

5.0

307.7

1051

2371

Z3229

NOMESCO Finland

Other healthcare associate professional

4.8

307.7

1093

2609

H84

ICPC

Presbyacusis

7.1

307.7

719

1112

R5120

NOMESCO Finland

Preparation of an aid

13.4

307.7

616

498

R4135

NOMESCO Finland

Rehabilitation for hearing problems

28.9

307.7

234

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

26.7

307.7

1769

888

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

28.3

307.7

799

317

Z01.1

ICD-10 Finland

Examination of ears and hearing

13.6

307.7

2310

2492

UDC00

NOMESCO Finland

Ear microscopy

12.9

307.7

1141

1044

H81

ICPC

Excessive ear wax

3.1

307.7

1895

7434

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

67.4

307.7

1092

192

Z97.4

ICD-10 Finland

Presence of external hearing-aid

30.0

307.7

1353

559

H93.1

ICD-10 Finland

Tinnitus

8.9

296.8

380

445

TDA90

NOMESCO Finland

Removal wax from ear

15.8

288.6

252

164

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.3

267.3

765

1948

H29

ICPC

Ear symptom/complaint other

3.4

244.7

1033

3421

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

41.0

226.7

138

Z97.8

ICD-10 Finland

Presence of other specified devices

50.4

197.9

115

DFX03

NOMESCO Finland

Review, maintenance and user education for hearing aid

46.8

181.3

107

A98

ICPC

Health maint/preventive medicine

2.7

170.6

5632

45151

R5599

NOMESCO Finland

Other rehabilitation service

5.6

167.5

331

615

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

45.2

166.4

N02BE01

ATC

paracetamol; systemic, rectal

2.7

156.7

5745

47032

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

7.4

145.9

215

296

SPAT1310

SPAT

Counselling related to known health issue

2.0

139.2

2127

12512

H90.5

ICD-10 Finland

Sensorineural hearing loss, unspecified

13.4

131.7

125

RK520, ,

NOMESCO Finland

29.4

131.6

R1260

NOMESCO Finland

Evaluation of communicative skills

5.9

126.7

234

407

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.9

124.2

2791

18492

N07CA01

ATC

betahistine; oral

3.0

123.4

609

2171

SPAT1263

SPAT

Sampling

1.9

122.4

2762

18302

SPAT1260

SPAT

Consultation of another employee

2.1

115.2

1310

6847

H25.1

ICD-10 Finland

Senile nuclear cataract

1.8

108.2

3118

21974

H28

ICPC

Limited function/disability (H)

8.2

107.1

144

178

SPAT1312

SPAT

General health counselling

1.9

106.4

1869

11329

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

106.1

3492

25515

H61.2

ICD-10 Finland

Impacted cerumen

2.8

102.6

543

2005

J01DB01

ATC

cefalexin; oral

1.8

98.0

4855

39480

SPAT1153

SPAT

Removal of sutures

1.8

97.3

2099

13485

TDA90, ,

SPAT

3.2

96.2

412

1350

SPAT1301

SPAT

No procedures

1.8

95.9

2286

15108

SPAT1325

SPAT

Vaccination

1.7

95.0

2580

17680

SPAT1053

SPAT

Memory test

1.9

92.5

1601

9589

ZXA10

NOMESCO Finland

Bilateral

1.9

91.4

1536

9110

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

90.3

1935

12352

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

90.1

2355

15905

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

89.5

3599

27249

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

89.5

3039

22012

A02BC02

ATC

pantoprazole; systemic

1.7

89.0

4288

34043

-44

ICPC

Preventive immunization/medic

2.3

88.5

793

3742

-1, ,

NOMESCO Finland

1.9

88.0

1540

9235

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

20.0

87.9

S18

ICPC

Laceration/cut

1.7

86.4

2879

20688

SPAT1097

SPAT

Recording of ECG

2.0

84.3

1177

6548

H04

ICPC

Ear discharge

3.6

84.2

291

833

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

21.0

83.1

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

81.0

1693

10670

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

203.0

78.1

M79.6

ICD-10 Finland

Pain in limb

1.7

76.2

2319

16130

H01

ICPC

Ear pain/earache

2.4

74.5

538

2305

R42

ICD-10 Finland

Dizziness and giddiness

1.7

74.0

1772

11553

R01AD09

ATC

mometasone; nasal

1.7

72.6

1992

13452

P20

ICPC

Memory disturbance

1.8

72.0

1463

9099

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

71.0

1335

8113

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.6

69.9

2825

20934

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

68.9

2001

13674

N40

ICD-10 Finland

Hyperplasia of prostate

1.7

68.5

1902

12847

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

68.1

3205

24549

R05

ICPC

Cough

1.8

68.1

1320

8081

L03

ICPC

Low back symptom/complaint

1.7

67.9

1456

9175

RK320, ,

NOMESCO Finland

6.8

66.4

104

153

AA1AD

NOMESCO Finland

CT of head and brain

1.6

63.6

2103

14773

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

28.6

63.5

SPAT1304

SPAT

Counselling and guidance related to ageing

1.9

63.2

848

4618

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

63.1

2813

21157

J01CA04

ATC

amoxicillin; systemic

1.6

62.4

4427

36878

R01AD12

ATC

fluticasone furoate; nasal

1.8

61.8

1093

6495

L08

ICPC

Shoulder symptom/complaint

1.8

61.5

1207

7392

M54.5

ICD-10 Finland

Low back pain

1.6

61.0

1813

12386

SPAT1262

SPAT

Handing over of treatment supplies

1.7

60.3

1258

7834

H92.0

ICD-10 Finland

Otalgia

3.2

59.3

241

763

SPAT1041

SPAT

Comprehensive hearing test

6.5

59.0

147

ZXC50

NOMESCO Finland

Cryotherapy

2.6

58.8

345

1337

Z01.9

ICD-10 Finland

Special examination, unspecified

2.4

57.3

420

1807

H90.8

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unspecified

18.3

57.2

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

57.1

920

5304

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

56.4

1423

9302

G04CA02

ATC

tamsulosin; oral

1.6

55.3

2009

14322

XKD00

NOMESCO Finland

Uroflowmetry

1.7

55.0

1286

8234

RK110, ,

NOMESCO Finland

6.2

54.8

152

SPAT1131

SPAT

Colonoscopy

2.8

54.2

275

988

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.6

54.0

326

1280

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

53.7

1778

12393

DFX03, ,

SPAT

20.4

53.4

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

53.4

1854

13063

L13

ICPC

Hip symptom/complaint

1.7

52.9

1196

7584

ZXE00

NOMESCO Finland

One hour or less

1.5

50.7

2403

18061

G04BD12

ATC

mirabegron; oral

1.8

50.6

906

5378

N17

ICPC

Vertigo/dizziness

1.8

50.4

908

5399

M01AH05

ATC

etoricoxib; oral

1.5

50.2

2762

21381

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

49.7

4502

38435

G47.3

ICD-10 Finland

Sleep apnoea

1.7

49.4

949

5746

R03AC02

ATC

salbutamol; inhalant

1.5

49.1

2841

22177

R02

ICPC

Shortness of breath/dyspnoea

1.8

48.9

909

5449

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

48.6

1966

14261

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.5

48.6

315

1280

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

48.0

1505

10314

H26.4

ICD-10 Finland

After-cataract

1.7

47.9

1032

6444

SPAT1377

SPAT

Polysomnography

3.4

47.9

176

524

H60.8

ICD-10 Finland

Other otitis externa

3.6

47.5

156

431

H80.9

ICD-10 Finland

Otosclerosis, unspecified

9.8

47.5

-69

ICPC

Other reason for encounter NEC

2.5

47.2

321

1334

RK120, ,

NOMESCO Finland

13.2

47.1

R06.0

ICD-10 Finland

Dyspnoea

1.5

47.0

1871

13507

L17

ICPC

Foot/toe symptom/complaint

1.5

46.7

1642

11536

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

8.6

46.7

H91

ICD-10 Finland

Other hearing loss

6.0

46.6

136

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

46.6

1945

14176

U04

ICPC

Incontinence urine

2.0

46.5

518

2632

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

46.5

867

5199

L15

ICPC

Knee symptom/complaint

1.6

45.3

1258

8364

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.8

45.2

234

850

H81.0

ICD-10 Finland

Ménière disease

3.8

45.1

141

377

H90.2

ICD-10 Finland

Conductive hearing loss, unspecified

17.5

45.0

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

4.4

45.0

112

253

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

44.8

1262

8418

L01

ICPC

Neck symptom/complaint

1.8

44.7

730

4208

R01AD58

ATC

fluticasone, combinations; nasal

1.8

44.6

714

4091

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

6.1

44.0

127

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

43.6

3001

24021

A44

ICPC

General and Unspecified, Preventive immunization/medic

2.0

43.5

497

2546

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

42.6

2331

17855

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

42.1

1901

14020

D07AC01

ATC

betamethasone; topical

1.5

41.5

2004

14968

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

41.4

1810

13253

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

41.2

1597

11408

H80.0

ICD-10 Finland

Otosclerosis involving oval window, nonobliterative

8.3

41.0

HAHOM, ,

NOMESCO Finland

5.4

40.9

147

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

40.6

1047

6818

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

40.6

416

2048

K02.1

ICD-10 Finland

Caries of dentine

1.4

40.1

2354

18213

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.5

40.0

257

1040

UKC02

NOMESCO Finland

Cystoscopy

1.6

39.7

1287

8836

SFA10

NOMESCO Finland

One-surface restoration

1.4

39.3

2278

17565

L57.0

ICD-10 Finland

Actinic keratosis

1.6

39.0

936

5985

C07AB07

ATC

bisoprolol; oral

1.4

38.8

3715

31258

KMAK, ,

NOMESCO Finland

1.4

38.8

2132

16271

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.8

38.7

619

3539

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

38.6

1328

9229

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

38.1

1862

13889

H91.8

ICD-10 Finland

Other specified hearing loss

6.2

38.0

105

A02BC05

ATC

esomeprazole; systemic

1.4

37.8

2238

17297

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

37.6

2293

17808

C10AA05

ATC

atorvastatin; oral

1.4

37.4

2785

22394

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

5.5

37.1

128

E0000UV, ,

ATC

1.4

36.8

2233

17309

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

36.8

1290

8991

SPAT1094

SPAT

Continuous Positive Airway Pressure

4.8

36.6

170

RK420, ,

NOMESCO Finland

99.7

36.6

SFA20

NOMESCO Finland

Two-surface restoration

1.4

36.5

2249

17475

S82

ICPC

Naevus/mole

1.7

36.4

669

3979

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

36.3

2222

17242

Z71.8

ICD-10 Finland

Other specified counselling

1.5

36.2

1464

10504

M25.5

ICD-10 Finland

Pain in joint

1.5

36.0

1341

9460

R05

ICD-10 Finland

Cough

1.6

35.5

1100

7458

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.5

35.4

1438

10320

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

35.4

2371

18669

L12

ICPC

Hand/finger symptom/complaint

1.7

35.3

775

4834

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

35.2

1079

7295

HMAK, ,

NOMESCO Finland

1.9

35.1

494

2711

SPAT1211

SPAT

Application of soft bandage

1.8

34.9

575

3312

D82

ICPC

Teeth/gum disease

1.5

34.8

1298

9154

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

34.6

1587

11658

J01AA02

ATC

doxycycline; systemic

1.4

34.6

4465

39137

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.7

34.3

764

4782

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

34.2

2307

18153

M03BX02

ATC

tizanidine; oral

1.4

34.2

2591

20792

H83.3

ICD-10 Finland

Noise effects on inner ear

6.3

34.1

Z00.0

ICD-10 Finland

General medical examination

1.5

34.0

1120

7686

A28

ICPC

Limited function/disability NOS

1.4

33.7

1648

12245

U02

ICPC

Urinary frequency/urgency

1.6

33.7

849

5480

B01AF02

ATC

apixaban; oral

1.5

33.4

1075

7338

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

33.4

4558

40190

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.6

32.9

193

747

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

32.8

860

5601

G04CA01

ATC

alfuzosin; oral

1.6

32.8

861

5611

WX723

NOMESCO Finland

CPAP therapy

2.9

32.7

158

553

C10AA01

ATC

simvastatin; oral

1.4

32.7

3369

28327

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

32.7

612

3655

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.7

32.6

714

4446

Z01.2

ICD-10 Finland

Dental examination

1.4

32.3

1733

13076

P06

ICPC

Sleep disturbance

1.9

32.3

465

2569

-51

ICPC

I&d/flush/aspiration

3.5

32.2

112

322

Z02.4

ICD-10 Finland

Examination for driving licence

1.4

32.2

1847

14101

R53

ICD-10 Finland

Malaise and fatigue

1.4

32.2

1597

11880

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

32.1

270

1229

OAB50, ,

SPAT

2.1

32.0

323

1579

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.7

31.9

601

3594

G04CB01

ATC

finasteride; oral

1.5

31.5

1011

6889

-31

ICPC

Medical examin/health eval partial

1.8

31.5

463

2575

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.1

31.4

326

1612

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

31.3

1194

8436

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

31.2

786

5068

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

30.9

1000

6823

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

30.9

1703

12893

RD211, ,

NOMESCO Finland

2.2

30.9

271

1256

H65.3

ICD-10 Finland

Chronic mucoid otitis media

4.5

30.7

167

N03AX12

ATC

[U] gabapentin; oral

1.6

30.7

869

5757

R51.80

ICD-10 Finland

Headache

1.7

30.5

612

3722

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

30.3

1899

14688

H02AB06

ATC

prednisolone; systemic

1.4

30.2

2787

22927

R01AD08

ATC

fluticasone; nasal

1.5

30.2

1141

8040

H60.3

ICD-10 Finland

Other infective otitis externa

3.4

29.9

110

328

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

29.9

973

6644

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

29.8

541

3202

ZXC15

NOMESCO Finland

Use of photodynamic technique

2.8

29.6

151

545

RK290, ,

NOMESCO Finland

10.3

29.4

M01AX05

ATC

glucosamine; oral

1.4

29.4

1469

10915

XCH00

NOMESCO Finland

Eye pressure measurement

2.0

29.2

348

1806

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

29.1

1693

12917

J01FA10

ATC

azithromycin; systemic

1.4

28.8

2322

18672

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

28.7

682

4330

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

28.6

313

1576

R21

ICPC

Throat symptom/complaint

1.7

28.6

622

3863

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.7

28.5

608

3757

M01AB05

ATC

diclofenac; systemic, rectal

1.3

28.3

3267

27690

A02BC01

ATC

omeprazole; systemic

1.4

28.2

1822

14129

SPAT1058

SPAT

PEF monitoring instruction

1.8

28.2

440

2490

DFF40

NOMESCO Finland

Otoneurologic examination of vertigo

9.9

27.9

R06AE07

ATC

cetirizine; oral

1.4

27.9

1994

15716

J01MA02

ATC

ciprofloxacin; systemic

1.3

27.7

2493

20347

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

27.7

521

3111

L28

ICPC

Limited function/disability (L)

1.4

27.7

1417

10555

G44.2

ICD-10 Finland

Tension-type headache

1.7

27.5

554

3369

SFA30

NOMESCO Finland

Three-surface restoration

1.4

27.4

1655

12681

A02BC03

ATC

lansoprazole; oral

1.4

27.1

1773

13760

K80

ICPC

Cardiac arrhythmia NOS

1.7

27.1

491

2902

R4110, ,

SPAT

1.8

27.0

434

2477

SPAT1252

SPAT

Overall medication plan or its review

1.7

27.0

544

3309

A04

ICPC

Weakness/tiredness general

1.5

26.9

971

6763

A11

ICPC

Chest pain NOS

1.7

26.9

518

3114

WX780

NOMESCO Finland

Remote monitoring CPAP

2.6

26.8

157

608

S21

ICPC

Skin texture symptom/complaint

1.5

26.7

812

5455

S29

ICPC

Skin symptom/complaint other

1.5

26.7

1057

7501

207

Kela drug reimbursment

Chronic arrhythmias

1.4

26.5

1405

10521

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

26.5

728

4781

L16

ICPC

Ankle symptom/complaint

1.7

26.3

518

3132

R01AD01

ATC

beclometasone; nasal

1.6

26.1

675

4369

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

26.0

1499

11379

R74

ICPC

Upper respiratory infection acute

1.5

25.8

869

5963

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

25.6

2180

17592

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.2

25.5

229

1072

WX144

NOMESCO Finland

Subconjunctival anesthesy

2.8

25.4

130

470

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

25.4

612

3893

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

25.0

2178

17618

WW200, ,

SPAT

1.5

25.0

1002

7119

N30.0

ICD-10 Finland

Acute cystitis

1.5

24.9

1017

7251

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

24.5

661

4318

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

24.5

633

4094

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.7

24.3

456

2719

UJF32

NOMESCO Finland

Coloscopy

1.4

24.2

1591

12319

H61.8

ICD-10 Finland

Other specified disorders of external ear

4.1

24.2

165

SCA02

NOMESCO Finland

Preventive oral health care

1.8

24.2

380

2155

A03

ICPC

Fever

1.6

24.0

562

3548

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

23.8

281

1453

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

23.8

343

1893

C08CA01

ATC

amlodipine; oral

1.3

23.7

2731

22924

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

23.7

768

5224

K86

ICPC

Hypertension uncomplicated

1.5

23.6

859

5981

B01AB05

ATC

enoxaparin; parenteral

1.3

23.6

1917

15316

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

23.6

641

4192

K30

ICD-10 Finland

Functional dyspepsia

1.6

23.3

515

3206

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

23.2

596

3848

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

23.2

964

6890

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

23.1

469

2856

C09CA01

ATC

losartan; oral

1.4

23.1

1643

12863

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

23.1

625

4085

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

23.1

3161

27124

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

22.9

673

4478

G04BD08

ATC

solifenacin; oral

1.6

22.9

500

3103

C09AA05

ATC

ramipril; oral

1.3

22.6

1931

15520

A97

ICPC

No disease

1.4

22.4

968

6965

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

22.3

2073

16860

N06AX11

ATC

mirtazapine; oral

1.3

22.3

1794

14295

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

22.2

883

6253

B01AC04

ATC

clopidogrel; oral

1.4

22.1

1303

9891

N01

ICPC

Headache

1.8

22.0

342

1933

SDA03

NOMESCO Finland

Periodontal treatment

1.4

22.0

1375

10538

R35

ICD-10 Finland

Polyuria

1.7

21.9

436

2641

R06.5

ICD-10 Finland

Mouth breathing

1.8

21.9

315

1739

G04CB02

ATC

dutasteride; oral

1.6

21.7

572

3713

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.2

21.6

186

856

C01DA14

ATC

isosorbide mononitrate; oral

1.3

21.6

1663

13153

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

21.6

1341

10263

H65.2

ICD-10 Finland

Chronic serous otitis media

3.9

21.6

157

WX720

NOMESCO Finland

Own respiration

2.0

21.4

223

1105

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

4.4

21.4

120

R06AX27

ATC

desloratadine; oral

1.4

21.2

878

6264

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

21.2

1218

9203

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

21.1

967

7024

WX320

NOMESCO Finland

Spinalanesthesy

1.4

21.0

1422

11024

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

21.0

1195

9014

WX402

NOMESCO Finland

General anaesthesia

1.5

20.9

835

5916

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

20.8

1241

9427

DFE00

NOMESCO Finland

Insertion of cochlear implant

+∞

20.8

H03

ICPC

Tinnitus, ringing/buzzing ear

3.0

20.7

303

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

20.7

590

3897

D01BA02

ATC

terbinafine; oral

1.4

20.6

1278

9767

R60.0

ICD-10 Finland

Localized oedema

1.4

20.6

843

5999

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

20.5

806

5691

H66.9

ICD-10 Finland

Otitis media, unspecified

2.3

20.4

154

672

WZC30

NOMESCO Finland

Teaching

1.5

20.1

773

5431

T16

ICD-10 Finland

Foreign body in ear

4.4

20.0

110

M48.0

ICD-10 Finland

Spinal stenosis

1.4

20.0

872

6276

R55

ICD-10 Finland

Syncope and collapse

1.4

19.9

837

5983

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

19.8

2312

19303

-1, ,

ICPC

2.0

19.8

216

1088

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

19.6

1008

7465

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

19.6

1096

8234

D11

ICPC

Diarrhoea

1.6

19.5

447

2807

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.6

19.5

416

2566

C03CA01

ATC

furosemide; systemic

1.3

19.5

2998

25890

H71

ICD-10 Finland

Cholesteatoma of middle ear

3.8

19.4

151

-30

ICPC

Medical examin/health eval complete

2.2

19.4

163

743

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

19.4

1507

11900

38699, ,

ICD-8 Finland

4.5

19.3

101

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

19.1

967

7140

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.8

19.1

297

1679

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

2.8

19.1

345

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.1

18.9

174

823

SPAT1351

SPAT

Extensive ear examination

4.3

18.9

111

R52.9

ICD-10 Finland

Pain, unspecified

1.6

18.8

471

3021

EBA00

NOMESCO Finland

Extraction of tooth

1.3

18.7

1517

12047

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

18.6

983

7308

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.3

18.6

138

598

S04

ICPC

Lump/swelling localized

1.6

18.6

468

3005

RK530, ,

NOMESCO Finland

99.4

18.5

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

18.4

730

5155

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

18.3

517

3406

DC1AD

NOMESCO Finland

Temporalbone CT

5.6

18.2

SCA03

NOMESCO Finland

Preventive oral health care, extensive

2.1

18.2

169

802

AN1

Coronary angiography

1.4

18.2

914

6734

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

18.2

377

2308

F29

ICPC

Eye symptom/complaint other

1.6

18.1

427

2698

WX002

NOMESCO Finland

Sedation and analgesia

1.4

18.0

1151

8816

F03

ICPC

Eye discharge

1.8

18.0

264

1466

N03AX16

ATC

[U] pregabalin

1.3

18.0

1219

9421

S02.51

ICD-10 Finland

Fracture of tooth, open

1.7

18.0

352

2122

M02AA07

ATC

piroxicam; topical

1.3

18.0

2209

18503

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

18.0

584

3965

XQ848

NOMESCO Finland

Dermatological photography

2.1

18.0

176

853

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

18.0

690

4844

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

17.9

922

6821

S02

ICPC

Pruritus

2.0

17.9

187

929

R31

ICD-10 Finland

Unspecified haematuria

1.4

17.8

741

5279

U01

ICPC

Dysuria/painful urination

1.6

17.8

396

2468

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

17.7

1081

8219

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

17.7

743

5302

DFF16

NOMESCO Finland

Speech-in-noise audiometry

+∞

17.6

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

17.6

1536

12302

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

17.5

214

1122

C10AA07

ATC

rosuvastatin; oral

1.3

17.5

1518

12151

R07

ICPC

Sneezing/nasal congestion

2.0

17.5

177

869

SPAT1359

SPAT

Use of symptom diary

2.2

17.5

142

640

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

17.4

395

2472

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

17.4

1000

7529

L14

ICPC

Leg/thigh symptom/complaint

1.6

17.4

453

2930

R04.0

ICD-10 Finland

Epistaxis

1.5

17.4

543

3655

S06.0

ICD-10 Finland

Concussion

1.5

17.2

577

3942

H02.3

ICD-10 Finland

Blepharochalasis

1.6

17.1

374

2321

L90

ICPC

Osteoarthrosis of knee

1.6

17.1

383

2392

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

16.9

580

3983

KED22

NOMESCO Finland

Transurethral resection of prostate

1.5

16.8

485

3209

K85

ICPC

Elevated blood pressure

1.4

16.8

1039

7911

R09

ICPC

Sinus symptom/complaint

1.8

16.8

235

1288

L05

ICPC

Flank/axilla symptom/complaint

1.7

16.7

304

1797

WZC00, ,

SPAT

1.6

16.7

406

2584

Z00.8

ICD-10 Finland

Other general examinations

1.6

16.7

368

2289

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.6

16.6

404

2571

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.6

16.6

348

2135

DFX00

NOMESCO Finland

Connecting cochlear implant

+∞

16.6

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

16.5

571

3926

R13

ICD-10 Finland

Dysphagia

1.6

16.4

393

2492

M01AC06

ATC

meloxicam; systemic, rectal

1.3

16.4

1782

14662

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

16.4

786

5739

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

16.4

273

1576

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

16.2

922

6926

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.6

16.2

386

2445

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

16.1

761

5542

XKC03

NOMESCO Finland

Water cystometry

2.0

16.1

181

923

WX290

NOMESCO Finland

Other blockage of nerve

1.3

16.0

1345

10697

S01

ICPC

Pain/tenderness of skin

1.8

16.0

238

1328

ZXA05

NOMESCO Finland

Left side

1.3

16.0

1628

13282

D01

ICPC

Abdominal pain/cramps general

1.5

15.9

475

3166

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

15.9

2281

19383

DDA00

NOMESCO Finland

Stapedotomy

6.7

15.9

SPAT1281

SPAT

Other administrative function

1.6

15.8

414

2681

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

15.8

952

7218

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

15.7

1344

10712

N02BF01

ATC

gabapentin; oral

1.6

15.7

337

2081

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

15.7

1716

14117

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

15.7

249

1417

RK220, ,

NOMESCO Finland

5.7

15.6

H51

ICPC

Ear, I&d/flush/aspiration

2.6

15.6

360

R15

ICD-10 Finland

Faecal incontinence

1.9

15.5

186

970

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

15.4

949

7214

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.5

15.4

491

3319

D07AC13

ATC

mometasone; topical

1.3

15.3

1400

11252

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

2.6

15.3

340

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.9

15.2

185

969

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

15.2

968

7396

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

15.1

876

6597

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

15.1

625

4446

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

15.1

690

4996

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

15.1

281

1674

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

15.0

421

2769

WVA30, ,

SPAT

1.7

15.0

249

1436

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

15.0

1374

11048

A01

ICPC

Pain general/multiple sites

1.5

14.9

512

3513

Z51.88

ICD-10 Finland

Other specified medical care

2.1

14.9

141

676

D19

ICPC

Teeth/gum symptom/complaint

1.4

14.8

921

7011

SPAT1254

SPAT

Administration of medicine

1.3

14.8

1011

7804

H27

ICPC

Fear of ear disease

3.2

14.7

177

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

14.6

508

3495

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

14.6

867

6553

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

14.6

246

1426

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.9

14.6

189

1012

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

14.5

1021

7914

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

14.4

367

2361

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.4

14.4

664

4814

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

14.3

208

1154

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

5.4

14.3

R96

ICPC

Asthma

1.5

14.2

435

2914

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

14.2

1228

9786

I49.5

ICD-10 Finland

Sick sinus syndrome

1.6

14.2

364

2348

S22

ICPC

Nail symptom/complaint

1.6

14.2

328

2065

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

14.1

943

7252

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

14.1

484

3321

L86

ICPC

Back syndrome with radiating pain

1.7

14.1

279

1689

XX2VW

NOMESCO Finland

Radiologic consultation

4.4

14.0

H40.0

ICD-10 Finland

Glaucoma suspect

1.5

14.0

459

3120

RK323, ,

NOMESCO Finland

6.1

14.0

D12

ICPC

Constipation

1.7

13.9

242

1414

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

13.8

1078

8469

XF600, ,

SPAT

2.0

13.8

150

756

P01AB01

ATC

metronidazole; oral, rectal

1.3

13.8

1778

14869

D02

ICPC

Abdominal pain epigastric

1.7

13.8

251

1485

OAB42, ,

SPAT

1.6

13.8

372

2425

M02AA10

ATC

ketoprofen; topical

1.3

13.8

863

6571

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

13.8

375

2451

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

13.7

284

1739

H60

ICD-10 Finland

Otitis externa

2.0

13.7

151

766

K76

ICPC

Ischaemic heart dis without angina

1.9

13.6

183

992

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

13.6

860

6559

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

+∞

13.5

D33.30

ICD-10 Finland

Acoustic neuroma

+∞

13.5

ZXA00

NOMESCO Finland

Right side

1.3

13.5

1703

14206

N02AX02

ATC

tramadol; systemic, rectal

1.2

13.5

2407

20847

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.5

13.4

364

2376

K05

ICPC

Irregular heartbeat other

1.8

13.4

207

1169

A02BA02

ATC

ranitidine; systemic

1.3

13.4

1275

10279

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.5

13.4

452

3090

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.6

13.4

355

2306

H91.0

ICD-10 Finland

Ototoxic hearing loss

138.9

13.4

F16

ICPC

Eyelid symptom/complaint

1.7

13.4

227

1318

SPAT1291

SPAT

Other function in accordance with NCSP classification

2.4

13.4

381

T90

ICPC

Diabetes non-insulin dependent

1.3

13.4

1379

11232

D06

ICPC

Abdominal pain localized other

1.6

13.3

347

2245

R08

ICPC

Nose symptom/complaint other

2.0

13.3

133

652

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

13.3

896

6897

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

13.2

334

2146

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

13.2

724

5397

-54

ICPC

Repair/fix-suture/cast/prosth device

2.0

13.2

138

687

J01FA09

ATC

clarithromycin; systemic

1.3

13.2

1206

9673

I95.1

ICD-10 Finland

Orthostatic hypotension

1.6

13.1

337

2173

R07.0

ICD-10 Finland

Pain in throat

1.8

13.1

200

1126

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

13.1

537

3809

S01EE01

ATC

latanoprost; ophthalmic

1.4

13.1

519

3661

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

13.1

2012

17142

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.8

13.0

191

1063

H66

ICD-10 Finland

Suppurative and unspecified otitis media

2.8

13.0

234

Z75.9

ICD-10 Finland

Unspecified problem related to medical facilities and other health care

4.1

13.0

F02

ICPC

Red eye

1.8

12.9

195

1095

M01AE02

ATC

naproxen; oral, rectal

1.2

12.9

2506

21858

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.4

12.9

628

4592

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

12.9

1056

8348

C09CA06

ATC

candesartan; oral

1.3

12.9

1148

9176

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.9

12.8

166

889

R06AE09

ATC

levocetirizine; oral

1.5

12.8

456

3151

XF402

NOMESCO Finland

ECG with work load test

1.4

12.8

620

4531

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.5

12.8

361

2379

J05AB01

ATC

aciclovir; systemic

1.3

12.8

1022

8053

SPAT1229

SPAT

Assessment of need for aid

1.4

12.7

554

3973

A08

ICPC

Swelling

1.5

12.7

340

2214

RK322, ,

NOMESCO Finland

11.4

12.7

A06AC51

ATC

ispaghula, combinations; oral

1.7

12.7

256

1558

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

12.6

1319

10752

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

12.6

392

2638

R03BA08

ATC

ciclesonide; inhalant

1.6

12.5

315

2024

SPAT1044

SPAT

Tympanometry

2.5

12.5

291

XF404

NOMESCO Finland

Ambulatory ECG

1.4

12.4

536

3838

R03DC03

ATC

montelukast; oral

1.4

12.4

599

4373

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.4

12.4

686

5120

RK111, ,

NOMESCO Finland

129.0

12.4

H80

ICD-10 Finland

Otosclerosis

24.1

12.4

S06

ICPC

Rash localized

1.6

12.4

296

1879

RK510, ,

NOMESCO Finland

9.2

12.4

K78

ICPC

Atrial fibrillation/flutter

1.4

12.2

645

4782

S22.3

ICD-10 Finland

Fracture of rib

1.5

12.2

374

2510

M79.1

ICD-10 Finland

Myalgia

1.4

12.2

524

3752

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

12.1

498

3535

K22

ICPC

Risk factor cardiovascular disease

1.5

12.1

353

2343

TQW80

NOMESCO Finland

Local dermatologic skincare

1.9

12.1

147

772

VALMI, ,

NOMESCO Finland

1.3

12.1

832

6418

XX2RW, ,

NOMESCO Finland

2.9

12.1

194

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

12.1

481

3396

F01

ICPC

Eye pain

2.1

12.0

108

509

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

2.0

12.0

123

609

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

12.0

244

1489

H05

ICPC

Bleeding ear

3.7

11.9

100

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

11.9

661

4939

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

1.8

11.8

167

921

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

3.0

11.8

170

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.4

11.8

539

3900

TQW40, ,

SPAT

1.6

11.8

286

1823

N06AX21

ATC

duloxetine; oral

1.5

11.7

437

3047

3870A

ICD-9 Finland

Otosclerosis involving oval window, nonobliterative

4.8

11.7

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

11.7

376

2547

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.4

11.6

551

4009

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

11.6

1140

9209

YHMAS, ,

NOMESCO Finland

3.7

11.6

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

11.6

581

4267

ACC51

NOMESCO Finland

Release of median nerve

1.6

11.6

285

1821

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

11.6

672

5052

SPAT1016

SPAT

Examination of vision

1.7

11.6

231

1403

D17

ICPC

Incontinence of bowel

2.5

11.6

290

S97

ICPC

Chronic ulcer skin

1.5

11.5

403

2776

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.3

11.5

773

5941

M01AX17

ATC

nimesulide; oral

1.2

11.5

1377

11390

N05CF01

ATC

zopiclone; oral

1.2

11.5

2100

18156

C05AA08

ATC

fluocortolone; rectal, topical

1.4

11.5

670

5043

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

11.5

523

3782

S15

ICPC

Foreign body in skin

1.5

11.4

304

1978

SPAT1059

SPAT

Spirometry at the office

1.6

11.4

246

1524

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

11.4

2009

17303

Z3231

NOMESCO Finland

Registered nurse

1.2

11.4

1594

13410

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

11.3

200

1177

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

11.3

275

1754

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.1

11.3

110

535

J01EA01

ATC

trimethoprim; systemic

1.2

11.3

1631

13763

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

3.3

11.3

128

C08CA13

ATC

lercanidipine; oral

1.3

11.2

926

7318

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

11.2

494

3552

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.9

11.2

133

694

S09

ICPC

Infected finger/toe

1.8

11.2

151

821

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

11.2

732

5603

H01.0

ICD-10 Finland

Blepharitis

1.7

11.1

214

1287

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

11.1

267

1697

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

11.1

270

1721

H81.3

ICD-10 Finland

Other peripheral vertigo

1.9

11.1

140

745

XQ855, ,

SPAT

2.9

11.1

176

B01AF01

ATC

rivaroxaban; oral

1.3

11.0

759

5850

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

11.0

637

4785

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

3.1

11.0

145

R44

ICPC

Respiratory, Preventive immunization/medic

2.1

11.0

104

500

WX723, ,

SPAT

4.5

11.0

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.5

11.0

1806

S70.0

ICD-10 Finland

Contusion of hip

1.6

11.0

274

1758

R51

ICD-10 Finland

Headache

1.8

11.0

166

935

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

10.9

359

2442

H03AA01

ATC

levothyroxine sodium; systemic

1.3

10.9

1187

9699

L04

ICPC

Chest symptom/complaint

1.6

10.9

274

1759

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

9.1

10.9

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.2

10.9

398

D01AE16

ATC

amorolfine; topical

1.4

10.9

630

4734

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.4

10.8

471

3377

L92

ICPC

Shoulder syndrome

2.0

10.8

117

591

L60.0

ICD-10 Finland

Ingrowing nail

1.7

10.8

204

1223

S10

ICPC

Boil/carbuncle

1.6

10.8

241

1507

S01BC05

ATC

ketorolac; ophthalmic

1.5

10.7

322

2153

SPAT1098

SPAT

Exercise ECG

2.0

10.7

118

601

AN2

Balloon angioplasty, including several vessels

1.7

10.7

202

1211

R81

ICPC

Pneumonia

1.7

10.7

182

1061

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.6

10.6

224

1380

W19

ICD-10 Finland

Unspecified fall

1.4

10.5

574

4272

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.5

10.5

338

2290

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

10.5

160

904

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.4

10.5

286

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.7

10.4

186

1097

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.6

10.4

266

1716

3891A

ICD-9 Finland

Deafness, Sensorineural deafness

+∞

10.4

H70

ICPC

Otitis externa

2.3

10.4

318

R06AX13

ATC

loratadine; oral

1.4

10.3

469

3388

AXX01, ,

SPAT

1.7

10.3

187

1108

A10BB01

ATC

glibenclamide; oral

0.6

10.3

228

3493

L18

ICPC

Muscle pain

1.7

10.3

182

1071

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

10.3

316

2121

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.6

10.3

212

G04BD09

ATC

trospium; oral

1.7

10.3

169

976

L02

ICPC

Back symptom/complaint

1.5

10.2

356

2451

H40.11

ICD-10 Finland

Low pressure glaucoma

1.8

10.2

151

845

R50.9

ICD-10 Finland

Fever, unspecified

1.3

10.2

747

5807

R01AD11

ATC

triamcinolone; nasal

1.5

10.2

319

2151

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

10.2

336

2290

114

Kela drug reimbursment

Glaucoma

1.3

10.2

731

5668

SPAT1039

SPAT

Otomicroscopy

2.5

10.1

260

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

10.1

164

942

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

10.1

865

6861

H70.1

ICD-10 Finland

Chronic mastoiditis

7.4

10.1

A10BK01

ATC

dapagliflozin; oral

1.5

10.0

307

2060

R00.2

ICD-10 Finland

Palpitations

1.5

10.0

274

1795

N04BC05

ATC

pramipexole; oral

1.4

10.0

427

3052

WNF00

NOMESCO Finland

Infection source and contact determination

3.3

9.9

108

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

9.9

504

3710

J02AC01

ATC

fluconazole; systemic

1.2

9.9

1457

12294

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.5

9.9

288

1913

F21, ,

ICPC

2.1

9.9

428

K07

ICPC

Swollen ankles/oedema

1.5

9.9

335

2296

F70

ICPC

Conjunctivitis infectious

2.2

9.8

389

N06AX26

ATC

vortioxetine; oral

1.6

9.8

203

1248

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

1.6

9.7

228

1443

R11

ICD-10 Finland

Nausea and vomiting

1.4

9.7

467

3407

R23

ICPC

Voice symptom/complaint

2.2

9.7

340

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

3.9

9.7

XQ845

NOMESCO Finland

Dermatoscopy

2.0

9.7

478

D21

ICPC

Swallowing problem

2.0

9.7

458

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

1.6

9.6

213

1329

F06.7

ICD-10 Finland

Mild cognitive disorder

1.6

9.6

228

1446

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

9.6

421

3023

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.6

9.6

217

1362

T92

ICPC

Gout

1.9

9.6

123

660

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

9.5

262

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

9.5

967

7832

H82

ICPC

Vertiginous syndrome

2.0

9.5

104

529

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

9.4

140

785

RK321, ,

NOMESCO Finland

9.9

9.4

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.6

9.4

216

1360

S01.0

ICD-10 Finland

Open wound of scalp

1.4

9.4

478

3519

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

9.4

449

3272

A02BC04

ATC

rabeprazole; oral

1.5

9.4

311

2121

-45

ICPC

Observ/health educat/advice/diet

1.8

9.4

148

845

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

9.4

175

1047

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

1.8

9.4

125

679

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.8

9.3

134

744

3882A

ICD-9 Finland

Other disorders of ear, Sudden hearing loss, unspecified

+∞

9.3

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

1.5

9.3

284

1905

R07.3

ICD-10 Finland

Other chest pain

1.4

9.3

501

3722

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.4

9.3

396

2830

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.7

9.3

150

862

J05AB11

ATC

valaciclovir; oral

1.3

9.3

607

4643

J45

ICD-10 Finland

Asthma

1.4

9.2

398

2852

SGA01

NOMESCO Finland

Emergency treatment

1.4

9.2

353

2476

ECB00

NOMESCO Finland

Suture of gingiva

1.7

9.2

158

924

R5110, ,

SPAT

1.4

9.2

394

2819

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.4

9.2

381

2710

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

9.2

990

8070

R83

ICPC

Respiratory infection other

1.3

9.2

532

3998

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

9.2

318

2189

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

9.1

1220

10179

R75

ICPC

Sinusitis acute/chronic

1.8

9.1

128

706

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

9.1

157

919

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

3.2

9.1

104

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

9.1

286

1930

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.1

9.1

415

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.6

9.1

217

1380

G04BD07

ATC

tolterodine; oral

1.4

9.1

370

2624

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.6

9.0

228

1468

EMAK, ,

NOMESCO Finland

1.8

9.0

132

737

D06BB10

ATC

imiquimod; topical

1.5

9.0

258

1707

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.3

9.0

767

6075

S16

ICPC

Bruise/contusion

1.6

9.0

181

1103

X58

ICD-10 Finland

Exposure to other specified factors

1.4

9.0

503

3757

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.6

9.0

204

1281

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

9.0

565

4295

K02

ICPC

Pressure/tightness of heart

1.8

9.0

133

745

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

9.0

205

1289

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.2

9.0

351

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.7

8.9

175

R12

ICD-10 Finland

Heartburn

1.5

8.9

298

2036

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

8.9

270

1809

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.5

8.9

268

1793

L11

ICPC

Wrist symptom/complaint

1.5

8.9

307

2111

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

8.9

327

2277

F13

ICPC

Eye sensation abnormal

1.9

8.9

110

584

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

8.9

2009

17617

DFF05, ,

SPAT

2.8

8.9

159

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

3.1

8.9

111

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

8.8

342

2403

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

8.8

415

3018

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

8.8

508

3817

XKX00

NOMESCO Finland

Pelvic floor electromyography

4.2

8.8

R03BA05

ATC

fluticasone; inhalant

1.3

8.7

794

6341

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

1.6

8.7

208

1322

M10.9

ICD-10 Finland

Gout, unspecified

1.4

8.7

437

3209

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.2

8.7

1641

14148

H71

ICPC

Acute otitis media/myringitis

3.1

8.7

112

-60

ICPC

Result test/procedure

1.4

8.7

329

2301

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

3.3

8.7

SPAT1118

SPAT

Haemorrhoid procedure

3.2

8.7

107

-40

ICPC

Diagnostic endoscopy

4.3

8.7

M01AH02

ATC

rofecoxib; oral

1.3

8.7

767

6103

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

4.8

8.7

Y85

ICPC

Benign prostatic hypertrophy

1.9

8.7

108

574

DFF00, ,

SPAT

2.9

8.7

139

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

1.7

8.7

143

828

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1.4

8.6

353

2506

D40

ICPC

Digestive, Diagnostic endoscopy

3.4

8.6

SPAT1054

SPAT

Examination of peripheral nervous system

2.0

8.6

404

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.3

8.6

523

3959

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.6

8.6

210

1344

H25.8

ICD-10 Finland

Other senile cataract

1.3

8.6

876

7095

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

8.6

389

2813

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.6

8.6

178

1096

SPAT1216

SPAT

Assessment of functional ability

1.2

8.5

1081

8966

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

1.6

8.5

185

1151

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

2.9

8.5

135

AA3AD

NOMESCO Finland

CT of face

2.7

8.5

157

H92.2

ICD-10 Finland

Otorrhagia

8.1

8.5

U71

ICPC

Cystitis/urinary infection other

1.4

8.5

317

2215

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

8.5

282

1927

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

3.3

8.5

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.9

8.5

100

523

-35

ICPC

Urine test

2.3

8.5

283

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

8.4

238

1572

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

8.4

313

2186

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

8.4

492

3705

M10

ICD-10 Finland

Gout

1.5

8.4

249

1663

G04BD11

ATC

fesoterodine; oral

1.6

8.4

187

1172

SPAT1202

SPAT

Intra-articular injection

1.6

8.3

178

1103

ZX114, ,

SPAT

2.4

8.3

229

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

8.3

469

3509

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.5

8.3

247

1649

K59.0

ICD-10 Finland

Constipation

1.4

8.3

355

2540

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

8.3

548

38990

ICD-8 Finland

Other deafness, Partialis uni-sive bilateralis

+∞

8.3

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

8.3

250

1676

K01

ICPC

Heart pain

2.0

8.3

465

R33

ICD-10 Finland

Retention of urine

1.3

8.2

596

4622

SPA02

NOMESCO Finland

Preparation for dental prosthetics

1.8

8.2

118

656

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.0

8.2

111

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

2.2

8.2

293

S08

ICPC

Skin colour change

1.5

8.2

272

1857

M19.8

ICD-10 Finland

Other specified arthrosis

1.6

8.2

171

1054

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

8.2

419

3089

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.6

8.2

193

1225

J01CA08

ATC

pivmecillinam; oral

1.2

8.2

2077

18360

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

1.5

8.2

211

1367

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.2

8.1

294

NG1DA

NOMESCO Finland

X-ray of knees

2.0

8.1

406

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

8.1

725

5778

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

8.1

390

2848

U05

ICPC

Urination problems other

1.4

8.1

310

2176

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

8.1

590

4582

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

8.0

777

6253

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

2.1

8.0

316

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.3

8.0

502

3820

P03

ICPC

Feeling depressed

1.6

8.0

197

1265

C10AA03

ATC

pravastatin; oral

1.3

8.0

482

3647

R49.09

ICD-10 Finland

Unspecified dysphonia

2.5

7.9

198

R03BA01

ATC

beclometasone; inhalant

1.3

7.9

701

5578

SPAT1360

SPAT

Extensive global examination

1.4

7.9

401

2951

A06AD11

ATC

lactulose; oral

1.2

7.9

1221

10321

H31

ICPC

Ear, Medical examin/health eval partial

6.2

7.9

R4180

NOMESCO Finland

Podiatric therapy

2.3

7.9

241

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.4

7.9

909

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

2.7

7.9

141

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.6

7.9

163

1003

AN4

Balloon angioplasty and drug eluding stent

1.5

7.9

209

1363

M75

ICD-10 Finland

Shoulder lesions

1.6

7.9

160

980

J01FA06

ATC

roxithromycin; oral

1.2

7.9

1986

17534

ZXD05

NOMESCO Finland

Urgent procedure

1.2

7.9

1661

14450

D01AE15

ATC

terbinafine; topical

1.4

7.9

357

2582

WX704

NOMESCO Finland

Intubation

1.4

7.9

304

2138

J01DA01

ATC

[U] cefalexin

1.2

7.8

3293

30230

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

7.8

294

2057

ZXH09

NOMESCO Finland

Procedure performed in other unit outside usual setting for the procedure

4.4

7.8

WPA44

NOMESCO Finland

Nursing home for palliative care

4.4

7.8

N48.4

ICD-10 Finland

Impotence of organic origin

2.0

7.8

420

I50

ICD-10 Finland

Heart failure

1.4

7.7

288

2012

K02

ICD-10 Finland

Dental caries

1.5

7.7

229

1530

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.4

7.7

345

2490

N06DX01

ATC

memantine; oral

1.3

7.7

759

6121

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.5

7.7

231

1548

N39.3

ICD-10 Finland

Stress incontinence

1.4

7.6

317

2258

U07

ICPC

Urine symptom/complaint other

1.4

7.6

390

2876

A51

ICPC

General and Unspecified, I&d/flush/aspiration

6.3

7.6

L29

ICPC

Musculoskeletal sympt/complt other

1.4

7.6

399

2954

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

7.6

260

1787

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

1.7

7.6

135

799

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.6

7.6

182

1161

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

7.6

190

1224

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.2

7.6

357

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

7.6

148

898

H25.0

ICD-10 Finland

Senile incipient cataract

1.4

7.6

411

3059

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

7.6

296

2086

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.2

7.6

951

7874

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.4

7.6

349

2531

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.3

7.6

555

4313

R06

ICPC

Nose bleed/epistaxis

1.7

7.6

140

838

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

7.6

172

1084

F05

ICPC

Visual disturbance other

1.7

7.5

139

831

ZY010

NOMESCO Finland

Hospital outpatient

1.7

7.5

129

756

H76

ICPC

Foreign body in ear

2.8

7.5

128

K08.80

ICD-10 Finland

Toothache NOS

1.5

7.5

201

1314

H80.1

ICD-10 Finland

Otosclerosis involving oval window, obliterative

8.8

7.5

H83.9

ICD-10 Finland

Disease of inner ear, unspecified

6.1

7.5

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

7.5

262

1811

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

7.4

185

1191

Z50.0

ICD-10 Finland

Cardiac rehabilitation

2.0

7.4

386

130

Kela drug reimbursment

Malignant tumour

0.7

7.4

327

4392

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.6

7.4

157

973

UDM02

NOMESCO Finland

Sinoscopy

2.0

7.4

346

D64.9

ICD-10 Finland

Anaemia, unspecified

1.2

7.4

794

6465

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.3

7.3

513

3961

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.7

7.3

137

823

KDV10

NOMESCO Finland

Internal urethrotomy

1.9

7.3

409

S00.0

ICD-10 Finland

Superficial injury of scalp

1.7

7.3

136

816

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

7.2

297

2113

-50

ICPC

Medication/prescr/renewal

1.5

7.2

225

1520

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.5

7.2

238

1627

R29

ICPC

Respiratory symptom/complaint other

1.5

7.2

242

1660

ZXD20

NOMESCO Finland

Day surgery

1.3

7.2

605

4787

M54.2

ICD-10 Finland

Cervicalgia

1.4

7.2

252

1743

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

7.1

601

4755

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

1.6

7.1

140

852

F92

ICPC

Cataract

2.3

7.1

215

N29

ICPC

Neurological sympt/complt other

1.8

7.1

533

I49.1

ICD-10 Finland

Atrial premature depolarization

1.6

7.1

168

1070

A10AA02, ,

ATC

0.5

7.0

1421

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.0

7.0

333

WYA10

NOMESCO Finland

Emergency care or similar visit

1.4

7.0

248

1718

M05BX04

ATC

denosumab; parenteral

1.4

7.0

376

2797

K08.3

ICD-10 Finland

Retained dental root

1.4

6.9

351

2585

AA5PD

NOMESCO Finland

CT examination of brain pefusion

2.2

6.9

230

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

6.9

520

4054

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

6.9

556

4374

R61

ICD-10 Finland

Hyperhidrosis

2.6

6.9

140

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

1.7

6.9

117

685

DFF59

NOMESCO Finland

Other assessment of balance

3.0

6.9

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

6.9

384

2871

SAA04

NOMESCO Finland

Special examination of mouth

1.5

6.9

177

1148

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

6.9

281

1997

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

6.9

2121

18975

WX400

NOMESCO Finland

Inhalation anesthesy

1.7

6.9

129

776

H81.2

ICD-10 Finland

Vestibular neuronitis

1.9

6.9

425

H43

ICPC

Ear, Other diagnostic procedure

6.2

6.9

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.7

6.9

110

634

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

6.9

415

3141

L84

ICPC

Back syndrome without radiat pain

1.5

6.8

198

1318

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

6.8

496

WPA13

NOMESCO Finland

Palliative consultation

3.2

6.8

J01AA07

ATC

tetracycline; systemic

1.3

6.8

458

3517

S01EE05

ATC

tafluprost; ophthalmic

1.5

6.8

217

1472

L29.9

ICD-10 Finland

Pruritus, unspecified

1.7

6.8

119

702

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

2.0

6.8

323

A03FA02

ATC

cisapride; oral, rectal

1.3

6.8

476

3676

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

6.8

232

1596

J20

ICD-10 Finland

Acute bronchitis

1.3

6.8

396

2981

R41.0

ICD-10 Finland

Disorientation, unspecified

1.4

6.8

248

1728

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.6

6.8

1457

R2110

NOMESCO Finland

Giving the first information

1.4

6.8

242

1679

Z04

ICD-10 Finland

Examination and observation for other reasons

1.9

6.8

441

N05CF02

ATC

zolpidem; oral

1.3

6.8

666

5367

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.4

6.8

290

2079

N35.9

ICD-10 Finland

Urethral stricture, unspecified

2.0

6.8

365

B01AA03

ATC

warfarin; systemic

1.2

6.8

1728

15240

S70

ICPC

Herpes zoster

1.6

6.7

141

872

SPAT1236

SPAT

Informing family of child’s disability

1.7

6.7

111

645

S02.5

ICD-10 Finland

Fracture of tooth

1.9

6.7

428

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.7

6.7

107

616

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

2.0

6.7

366

M01AH03

ATC

valdecoxib; oral

1.4

6.7

247

1724

SBB10

NOMESCO Finland

Dental impressions

1.6

6.7

158

1006

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

6.7

129

782

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

6.7

359

2670

A29

ICPC

General symptom/complaint other

1.2

6.7

702

5700

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.7

6.7

118

699

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.6

6.7

133

813

D06BX01

ATC

metronidazole; topical

1.3

6.7

394

2973

A10

ICPC

Bleeding/haemorrhage NOS

2.2

6.6

228

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.1

6.6

267

D93

ICPC

Irritable bowel syndrome

2.6

6.6

143

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.7

6.6

119

708

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.7

6.6

113

663

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

6.6

138

853

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.4

6.6

299

2165

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.5

6.6

208

1410

M01AC01

ATC

piroxicam; systemic, rectal

1.2

6.6

695

5646

KED33

NOMESCO Finland

Transurethral incision of prostate

1.9

6.6

446

M54

ICD-10 Finland

Dorsalgia

1.3

6.6

417

3180

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.6

6.5

131

802

R5140, ,

SPAT

2.2

6.5

217

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

6.5

685

5561

R30.0

ICD-10 Finland

Dysuria

1.6

6.5

162

1044

FP4B5, ,

SPAT

2.7

6.5

127

S01ED51

ATC

timolol, combinations; ophthalmic

1.3

6.5

554

4389

SPAT1101

SPAT

Orthostatic test

1.4

6.5

320

2348

R04

ICPC

Breathing problem other

1.6

6.5

144

904

J01

ICD-10 Finland

Acute sinusitis

1.7

6.5

122

735

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

1.7

6.5

106

615

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

1.4

6.5

255

1802

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.5

6.5

187

1245

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.3

6.5

641

5170

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.4

6.4

313

2292

C61

ICD-10 Finland

Malignant neoplasm of prostate

1.2

6.4

675

5480

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

1.8

6.4

492

M54.1

ICD-10 Finland

Radiculopathy

1.6

6.4

145

914

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

1.8

6.4

558

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

1.6

6.4

128

784

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.3

6.4

515

4055

F05.9

ICD-10 Finland

Delirium, unspecified

1.5

6.3

159

1027

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

6.3

331

2452

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.3

6.3

486

3801

S03

ICPC

Warts

1.9

6.3

367

WPA11

NOMESCO Finland

Developing a plan for palliative care

3.5

6.3

S01EC04

ATC

brinzolamide; ophthalmic

1.4

6.3

279

2012

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.5

6.3

175

1156

T29

ICPC

Endocr/metab/nutr sympt/compl other

1.8

6.3

488

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.5

6.3

217

1497

CBB30

NOMESCO Finland

Excision of lesion of eyelid

1.5

6.3

158

1021

QXB99, ,

SPAT

1.8

6.3

467

M15

ICD-10 Finland

Polyarthrosis

1.4

6.3

276

1989

ZXE20

NOMESCO Finland

More than three and less than five hours

1.2

6.3

741

6095

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.4

6.2

316

2330

H02.4

ICD-10 Finland

Ptosis of eyelid

1.6

6.2

141

890

H91.3

ICD-10 Finland

Deaf mutism, not elsewhere classified

+∞

6.2

H60.1

ICD-10 Finland

Cellulitis of external ear

2.5

6.2

142

S01AD03

ATC

aciclovir; ophthalmic

1.5

6.2

164

1072

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

6.2

365

2754

R07.2

ICD-10 Finland

Precordial pain

1.7

6.2

105

616

S01.3

ICD-10 Finland

Open wound of ear

2.1

6.2

268

4289X

ICD-9 Finland

Heart failure, unspecified

0.2

6.2

331

S26

ICPC

Fear of cancer of skin

1.9

6.2

370

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.5

6.2

153

986

M79.7

ICD-10 Finland

Fibromyalgia

1.8

6.2

470

S76.4

ICD-10 Finland

Injury of other and unspecified muscles and tendons at thigh level

2.6

6.2

131

E03

ICD-10 Finland

Other hypothyroidism

1.4

6.2

242

1711

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

1.4

6.1

318

2353

TKD00

NOMESCO Finland

Dilatation of urethra

2.1

6.1

269

WX140

NOMESCO Finland

Parabulbar anesthesy

1.4

6.1

275

1989

H65.0

ICD-10 Finland

Acute serous otitis media

2.4

6.1

167

R44.1

ICD-10 Finland

Visual hallucinations

2.4

6.1

167

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.6

6.1

125

770

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.8

6.1

428

D16

ICPC

Rectal bleeding

1.7

6.1

104

611

G25.0

ICD-10 Finland

Essential tremor

1.6

6.1

140

887

N81.6

ICD-10 Finland

Rectocele

1.4

6.1

283

2059

H74.1

ICD-10 Finland

Adhesive middle ear disease

5.3

6.1

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

6.1

350

2632

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

2.0

6.1

290

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.6

6.1

121

741

M54.3

ICD-10 Finland

Sciatica

1.4

6.1

234

1649

B02.9

ICD-10 Finland

Zoster without complication

1.3

6.1

343

2573

L89

ICPC

Osteoarthrosis of hip

1.5

6.1

192

1304

K03.66

ICD-10 Finland

Tooth plaque

1.4

6.0

262

1884

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.2

6.0

643

5229

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.6

6.0

142

905

XJH10

NOMESCO Finland

Anorectal manometry

3.4

6.0

H10

ICD-10 Finland

Conjunctivitis

1.5

6.0

183

1233

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002385) Erythrocyte distribution width [Ratio]

4798

35682

2.24

176.83

24.2

22.8

14.57

15.45

36.30

4653

34799

(40761536) Microorganisms panel - Urine sediment

995

3913

2.79

170.58

5.4

4.6

—

(40761511) CBC panel - Blood by Automated count

5468

43365

2.51

167.04

21.3

18.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5653

45734

2.65

161.71

24.9

23.1

139.34

139.41

mmol/l

1.20

5480

44251

(3023103) Potassium [Moles/volume] in Serum or Plasma

5656

45789

2.65

161.21

25.3

23.3

4.01

mmol/l

0.03

5474

44224

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5446

43404

2.45

159.30

20.0

19.1

25.86

29.07

mg/l

10.64

4649

36371

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5572

44873

2.55

159.14

23.9

22.7

88.57

86.26

umol/l

3.77

5572

44844

(3031040) Bacteria [#/volume] in Urine by Automated count

4503

33382

2.08

156.60

6.1

5.5

1677.47

2245.98

e6/l

0.40

138

637

(3010813) Leukocytes [#/volume] in Blood

5672

46195

2.62

155.59

30.0

27.7

7.14

7.10

e9/l

0.29

5439

44119

(3035941) MCH [Entitic mass]

5671

46189

2.62

155.44

29.9

27.6

30.43

30.40

0.83

5539

44974

(3009542) Hematocrit [Volume Fraction] of Blood

5670

46178

2.62

155.41

30.2

27.9

38.50

38.51

0.04

5084

42084

(3024731) MCV [Entitic volume]

5671

46191

2.62

155.38

29.9

27.7

92.08

91.98

0.95

5539

44974

(3026361) Erythrocytes [#/volume] in Blood

5671

46191

2.62

155.38

30.0

27.7

4.28

4.30

e12/l

1.92

5430

44109

(3000963) Hemoglobin [Mass/volume] in Blood

5671

46199

2.62

155.18

30.3

27.9

129.41

129.64

g/l

0.53

5536

44994

(3007461) Platelets [#/volume] in Blood

5670

46188

2.62

155.15

30.0

27.7

231.68

238.59

e9/l

12.28

5472

44354

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5103

39797

2.23

153.42

6.9

6.7

41.82

41.52

mmol/mol

1.31

4267

35579

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5529

44685

2.45

150.98

11.7

11.1

23.08

23.54

u/l

0.77

5117

42320

(3041096) Erythrocytes [Presence] in Urine by Automated

2006

11307

2.09

149.70

4.5

4.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5028

39211

2.17

147.56

5.2

4.8

2.11

2.13

mu/l

0.25

4169

34569

(3037467) Urinalysis macro (dipstick) panel - Urine

4418

32887

2.02

146.89

5.3

4.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5190

41200

2.20

141.99

5.5

5.1

6.12

6.15

mmol/l

1.02

4053

35947

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5172

41150

2.17

138.30

5.6

5.3

2.38

2.48

mmol/l

11.08

4135

36357

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5020

39542

2.11

137.07

4.9

4.6

4.25

4.35

mmol/l

8.58

4098

35029

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1039

4702

2.41

130.93

4.1

3.8

1.22

1.23

mmol/l

0.74

826

4053

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1213

5877

2.28

130.56

4.2

3.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4351

32854

1.93

130.44

4.6

4.2

15.91

16.46

mm/h

1.12

3729

29615

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4946

39041

2.04

129.89

4.9

4.6

1.42

1.45

mmol/l

3.22

3901

34317

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4686

36326

1.98

129.21

7.4

7.3

81.88

83.28

u/l

0.69

4234

33721

(3021589) Normoblasts [#/volume] in Blood

2942

19710

1.87

127.38

13.3

10.3

0.00

e9/l

0.31

2415

15802

(3044889) 12 lead EKG panel

4235

31849

1.90

126.62

5.2

4.5

—

(3018418) pH of Serum or Plasma

2588

16694

1.89

125.80

4.2

3.8

7.40

1.72

731

3040

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4226

31805

1.89

125.50

4.2

3.9

15.22

15.23

pmol/l

0.14

3443

27880

(3022217) INR in Platelet poor plasma by Coagulation assay

3739

27207

1.84

122.10

22.1

21.1

1.36

1.43

inr

2.93

1455

7371

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4788

37694

1.96

122.02

4.2

4.1

1.21

1.24

mmol/l

3.05

3716

32665

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3453

24616

1.82

119.58

5.5

5.8

1.21

mmol/l

3.76

2998

22126

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4960

39680

1.98

118.36

21.1

18.8

66.28

67.97

ml/min/173m2

7.48

4172

32883

(1761868) Lipid panel - Serum or Plasma

1680

9601

1.99

115.63

3.8

3.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3707

27262

1.80

113.09

6.1

6.4

1.22

1.21

mmol/l

3.62

2779

22841

(3013826) Glucose [Moles/volume] in Serum or Plasma

3936

29539

1.80

111.36

4.6

4.7

6.87

6.96

mmol/l

1.79

3734

27701

(3009261) Glucose [Presence] in Urine by Test strip

3217

22941

1.76

106.62

4.5

4.4

0.00

estimate

0.50

979

4125

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2808

19257

1.78

106.56

2.3

2.2

81.60

80.23

nmol/l

1.61

2278

16458

(3035350) Ketones [Presence] in Urine by Test strip

3191

22727

1.76

106.00

4.4

4.3

0.00

estimate

1.54

1026

4610

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1731

10271

1.91

105.02

1.6

1.25

1.27

mmol/l

0.50

1094

8475

(3021601) Nitrite [Presence] in Urine by Test strip

3172

22646

1.75

103.65

5.6

5.8

0.00

estimate

-0.00

982

4142

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1912

11806

1.85

101.88

1.9

1.7

6795835.35

16224156.25

pmol/l

0.64

1295

9369

(3000850) Epithelial cells [#/volume] in Urine

1937

12207

1.81

95.39

3.0

2.8

5.46

5.22

e6/l

0.34

1709

10881

(3029937) Albumin [Presence] in Urine by Test strip

1961

12450

1.80

93.94

4.9

4.8

0.00

estimate

0.34

933

3927

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2482

16951

1.73

91.57

4.9

4.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2940

21027

1.70

91.46

4.9

4.4

88.91

98.66

ng/l

0.11

2357

16806

(3002582) Erythrocytes [#/volume] in Urine

2490

17225

1.70

86.24

3.8

3.6

206.62

100.66

e6/l

0.80

1950

13370

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2576

18005

1.69

85.66

2.3

2.2

—

(3018095) Leukocytes [#/volume] in Urine

2686

19158

1.66

81.43

4.4

4.1

139.29

146.11

e6/l

0.13

2024

14040

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2704

19348

1.65

80.76

3.3

3.2

2186.06

2248.60

ng/l

0.24

2223

16922

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2421

17067

1.64

75.17

6.0

5.6

7.07

4.94

ug/l

0.39

1937

14873

(40760892) CBC W Ordered Manual Differential panel - Blood

2817

20622

1.62

75.04

6.3

5.8

—

(36304419) Bacteria [Presence] in Urine

2193

15115

1.66

74.20

3.6

3.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2578

18558

1.62

72.95

3.1

2.9

164.47

156.20

ug/l

0.27

2130

16562

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2156

14882

1.65

72.03

2.5

60.74

66.02

u/l

0.43

1899

13577

(40767503) Oxygen content in Capillary blood by calculation

353

1264

2.87

70.14

2.7

2.5

16.06

15.71

0.75

177

661

(3030467) Casts [#/volume] in Urine by Automated count

2246

15745

1.63

70.07

3.7

3.5

0.56

0.55

e6/l

0.04

1751

12208

(3006504) Eosinophils/100 leukocytes in Blood

2834

21101

1.58

68.15

5.6

5.5

2.75

2.79

0.45

2557

19285

(3019069) Monocytes/100 leukocytes in Blood

2843

21195

1.58

67.91

5.9

9.06

8.98

0.56

2565

19390

(3022096) Basophils/100 leukocytes in Blood

2771

20559

1.58

67.43

5.6

5.5

0.63

0.62

0.37

2495

18794

(3002030) Lymphocytes/100 leukocytes in Blood

2873

21526

1.57

66.79

5.7

5.8

24.81

24.71

0.17

2596

19729

(3021960) Folate [Moles/volume] in Serum or Plasma

2037

14123

1.62

65.45

1.7

1.6

20.26

19.76

nmol/l

0.66

1582

12031

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3311

25719

1.56

64.94

5.4

5.7

12.60

12.63

umol/l

0.04

3079

24222

(3018010) Neutrophils/100 leukocytes in Blood

2814

21123

1.56

63.98

5.4

5.5

59.86

59.79

0.09

2534

19366

(3012501) Base excess in Blood by calculation

346

1306

2.71

62.12

3.8

4.5

2.61

2.87

mmol/l

0.80

211

919

(3013290) Carbon dioxide [Partial pressure] in Blood

346

1308

2.71

61.93

3.8

4.5

4.84

5.03

kpa

3.94

340

1263

(3027315) Oxygen [Partial pressure] in Blood

346

1313

2.70

61.47

3.8

4.5

8.40

8.22

kpa

1.28

340

1267

(3028271) Lactate [Moles/volume] in Capillary blood

277

939

3.01

60.68

2.0

1.9

1.64

1.68

mmol/l

0.36

271

917

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1956

13639

1.60

60.34

5.3

4.8

22.48

22.44

0.04

981

7482

(3026008) Bacteria identified in Urine by Culture

2605

19427

1.55

59.69

3.9

3.7

—

(3025159) Blasts/100 leukocytes in Blood

680

3499

2.03

59.47

3.9

3.6

0.53

0.31

0.26

181

1038

(3026782) Osmolality of Urine

1722

11809

1.60

56.21

3.1

511.66

537.68

mosm/kgh2o

6.68

1464

10039

(3013115) Eosinophils [#/volume] in Blood

2951

22851

1.51

55.32

5.3

5.4

0.20

e9/l

0.15

2511

19261

(3019309) Folate [Moles/volume] in Red Blood Cells

1865

13074

1.58

55.26

2.0

1.8

1224.24

1164.08

nmol/l

1.67

1239

9556

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2994

23322

1.50

54.11

3.1

3.0

58.40

57.89

u/l

0.07

2557

20666

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1457

9705

1.63

53.16

3.6

3.3

0.87

0.88

ug/l

0.18

974

7220

(3002179) Metamyelocytes/100 leukocytes in Blood

666

3538

1.96

52.93

3.7

3.5

0.52

0.63

0.79

192

1225

(3024561) Albumin [Mass/volume] in Serum or Plasma

3026

23706

1.49

52.66

4.4

33.96

33.93

g/l

0.11

2659

21554

(3001604) Monocytes [#/volume] in Blood

2858

22145

1.49

52.43

5.1

5.2

0.66

0.64

e9/l

1.82

2365

18433

(3010421) pH of Blood

360

1509

2.44

51.96

4.0

4.3

7.43

7.42

2.33

350

1347

(3006315) Basophils [#/volume] in Blood

2863

22238

1.49

51.62

5.1

5.2

0.04

e9/l

0.41

2366

18536

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2073

15060

1.53

51.59

2.4

2.3

2.94

3.18

mg/l

4.87

1643

12635

(3015377) Calcium [Moles/volume] in Serum or Plasma

2446

18406

1.50

51.50

2.9

3.3

2.35

mmol/l

1.46

2032

15616

(3021440) Promyelocytes/100 leukocytes in Blood

691

3759

1.92

51.10

3.9

3.6

0.11

0.10

0.08

191

1275

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2195

16186

1.52

50.73

2.1

208.37

224.06

u/l

0.46

1997

14982

(3017181) Myelocytes/100 leukocytes in Blood

716

3954

1.89

50.55

3.9

3.6

0.89

0.94

0.17

215

1461

(3019198) Lymphocytes [#/volume] in Blood

2902

22667

1.48

50.50

5.2

5.4

1.89

1.88

e9/l

0.04

2506

19263

(3013650) Neutrophils [#/volume] in Blood by Automated count

3250

26122

1.46

47.87

7.5

8.1

4.53

4.49

e9/l

0.35

2762

22214

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1472

10057

1.58

47.53

1.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2950

23357

1.46

46.51

2.2

92.43

91.48

pmol/l

0.47

1381

11912

(3023368) Bacteria identified in Blood by Culture

2254

16942

1.48

46.42

4.4

4.3

—

(1616796) Gas panel - Central venous blood

319

1354

2.40

44.73

3.6

3.7

—

(3015736) pH of Urine

2369

18274

1.45

41.39

3.7

4.0

6.00

5.86

0.41

500

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1206

8141

1.57

40.16

2.7

2.6

21.42

20.37

1.83

961

6851

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1254

8553

1.56

39.87

2.6

2.5

2.23

g/l

0.01

1100

7783

(3022948) Iron [Moles/volume] in Serum or Plasma

1327

9194

1.54

39.23

2.6

2.5

27.45

11.28

umol/l

0.51

1197

8375

(3006184) Hemoglobin [Mass/volume] in Capillary blood

307

1379

2.26

37.74

2.6

2.2

127.45

125.26

g/l

0.87

265

1013

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1364

9634

1.51

36.50

1.6

1.7

1.48

1.64

mg/l

0.71

1012

7571

(40768804) Tissue Pathology biopsy report

2244

17501

1.41

35.38

2.5

2.3

—

(40768797) Stomach Pathology biopsy report

921

6017

1.60

34.82

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1076

7302

1.55

34.46

1.3

1.2

1.54

1.63

u/ml

0.10

238

1675

(3026493) Urate [Moles/volume] in Serum or Plasma

1651

12388

1.43

31.64

2.8

2.9

4574.49

7752.60

umol/l

2.06

1262

10311

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1563

11615

1.44

31.57

4.7

4.3

244.11

472.94

ng/l

1.83

1437

10389

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1046

7193

1.52

31.24

1.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1700

12871

1.42

30.83

3.0

37.75

37.30

u/l

0.06

1540

11975

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

210

880

2.41

30.31

3.5

3.4

56.65

60.01

2.72

210

880

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1038

7187

1.51

29.89

1.9

1.8

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

555

3305

1.72

29.86

5.2

5.9

24.50

24.91

mmol/l

1.82

549

3260

(3013512) EKG study

1907

14864

1.38

28.74

4.7

4.6

—

(3022145) Colonoscopy Study observation

694

4426

1.62

28.66

1.3

—

(3012516) Albumin [Mass/volume] in Urine

1929

15154

1.37

27.41

3.3

3.2

592.35

391.22

mg/l

0.81

1137

9779

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2624

21681

1.33

26.45

2.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

933

6471

1.50

26.38

1.6

1.4

2.66

2.81

g/l

0.87

477

3403

(3000012) Reticulocyte production index

222

1015

2.21

26.17

2.4

2.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

232

1088

2.15

25.67

3.3

2.4

1.86

mg/l

0.01

197

945

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

891

6173

1.50

25.24

3.6

3.1

255.90

292.50

ng/l

1.79

817

5645

(3047181) Lactate [Moles/volume] in Blood

309

1624

1.93

24.99

4.6

5.2

1.34

1.37

mmol/l

0.19

255

1432

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1183

8688

1.43

24.68

1.8

1.9

30.40

30.25

0.37

1129

8392

(3002256) Pathology report gross observation

887

6167

1.49

24.66

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

1910

15181

1.35

24.59

3.3

3.1

6.51

6.68

mmol/l

1.06

1363

12305

(3040151) Glucose [Moles/volume] in Capillary blood

174

743

2.36

24.13

4.3

10.1

7.16

7.50

mmol/l

0.75

142

610

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

126

475

2.66

22.77

1.6

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1039

7571

1.43

22.43

2.5

2.2

1.79

1.78

0.21

862

6495

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

832

5838

1.47

21.92

1.3

1.2

48.23

43.26

iu/ml

0.27

261

1791

(3021901) Oxygen saturation in Capillary blood

245

1255

1.97

21.39

2.7

2.9

—

(3042631) Mycobacterium sp identified in Specimen

180

826

2.19

21.09

3.4

2.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

295

1623

1.84

20.73

2.8

3.2

25.01

25.07

mmol/l

0.08

287

1585

(3023520) Reticulocytes [#/volume] in Blood

789

5548

1.46

20.49

2.9

2.3

67.09

68.08

e9/l

0.32

570

4133

(3020682) Albumin/Creatinine [Ratio] in Urine

1965

16057

1.30

19.88

3.9

3.7

10.23

10.37

mg/mmol

0.05

1064

10103

(3028626) Oxygen [Partial pressure] in Capillary blood

267

1458

1.85

19.23

2.7

2.9

7.75

7.69

kpa

0.25

259

1421

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

138

592

2.34

19.02

1.5

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

179

861

2.09

18.63

3.5

3.2

—

(3039000) Anion gap in Blood

213

1119

1.92

17.32

5.1

5.9

11.45

11.28

mmol/l

0.25

186

987

(3018572) Chloride [Moles/volume] in Blood

213

1119

1.92

17.32

5.1

5.9

104.51

105.01

mmol/l

0.69

186

987

(3036481) Cortisol [Moles/volume] in Serum or Plasma

549

3708

1.51

17.32

1.9

2.1

378.71

390.08

nmol/l

0.58

494

3304

(3049717) Cytology report of Urine Cyto stain

404

2556

1.60

17.06

2.8

2.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

754

5445

1.42

16.80

1.3

1.2

11.99

17.05

u/ml

1.00

221

1794

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

322

2.67

15.88

4.7

3.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

205

1100

1.87

15.66

1.5

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

276

1620

1.72

15.60

1.3

1.2

161.25

262.41

u/ml

2.99

244

1462

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

395

2549

1.57

15.33

1.9

1.8

3.53

2.61

ug/l

0.36

332

2172

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

320

2.62

15.01

1.6

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

147

714

2.06

14.99

1.5

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

321

2.61

14.92

1.6

1.4

—

(3000494) Fungus identified in Specimen by Culture

645

4651

1.41

14.41

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

209

1159

1.81

14.40

1.5

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

532

3707

1.46

14.32

2.0

1.8

161.73

180.66

ug/g

0.53

371

2838

(3004588) Protein electrophoresis panel - Serum or Plasma

612

4394

1.42

14.00

2.2

2.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

429

2878

1.51

13.95

3.4

2.6

10.37

10.94

g/l

1.52

379

2590

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1110

8748

1.31

13.94

2.7

0.82

0.81

mmol/l

0.69

990

7954

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

469

3218

1.48

13.66

1.4

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

262

1581

1.67

13.40

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

484

3369

1.46

13.09

3.3

3.7

2.30

2.15

mmol/l

0.36

333

2483

(3009343) pH of Capillary blood

498

3488

1.45

13.04

3.3

3.7

7.42

0.54

145

460

(3028026) IgM [Mass/volume] in Serum or Plasma

349

2282

1.54

12.80

2.3

1.8

1.67

1.39

g/l

0.54

299

2000

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1417

11633

1.26

12.77

3.1

2.47

mmol/l

0.72

1191

9915

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

501

3534

1.44

12.62

3.3

3.7

5.11

5.18

kpa

0.89

463

3315

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

459

3191

1.46

12.50

1.3

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

162

869

1.87

12.47

1.5

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

429

2950

1.47

12.36

2.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

140

718

1.95

12.34

1.2

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

646

4798

1.37

12.05

1.9

2.0

0.19

g/l

0.59

565

4356

(3035320) C reactive protein [Mass/volume] in Body fluid

354

2.34

11.76

2.5

2.7

—

(3037522) Nuclear Ab [Titer] in Serum

616

4571

1.37

11.54

1.3

467.52

486.64

titre

0.12

157

1060

(3025941) Bacteria identified in Stool by Culture

335

2223

1.52

11.50

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

258

1618

1.60

11.37

2.8

3.0

—

(3004451) EKG impression Narrative

301

2.42

11.17

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

330

2197

1.51

11.16

2.9

45.43

60.25

mg/l

0.65

215

1787

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

425

2982

1.44

11.03

7.4

8.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

330

2206

1.51

10.95

2.9

57.27

86.20

mg/l

0.56

216

1794

(3015171) Extractable nuclear Ab [Units/volume] in Serum

209

1259

1.67

10.83

1.3

1.2

2.12

0.94

u/ml

0.45

114

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

321

2139

1.51

10.82

2.8

2.9

1.40

3.17

ratio

1.27

154

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

377

2.22

10.60

1.6

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

597

4477

1.35

10.44

1.5

1.6

—

(3023419) Bacteria identified in Sputum by Culture

141

774

1.82

10.16

2.4

2.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

687

5299

1.32

9.91

2.6

2.4

65.41

65.67

g/l

0.39

583

4654

(36660697) Celiac disease serology panel - Serum

366

2556

1.44

9.76

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

291

1953

1.50

9.51

2.8

2.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

500

3703

1.37

9.48

5.1

6.0

24.50

24.57

mmol/l

0.13

463

3510

(3019150) Specific gravity of Urine by Refractometry

1215

10101

1.23

9.46

4.6

4.9

1.02

kg/l

0.01

244

1742

(3042111) Morphology [Interpretation] in Bone marrow Narrative

166

979

1.70

9.37

1.3

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

132

729

1.81

9.36

1.6

1.3

—

(3016750) Collection duration of Urine

327

2.19

8.90

2.4

2.0

485.24

504.63

min

0.71

224

(3007930) Methemoglobin/Hemoglobin.total in Blood

335

2357

1.43

8.61

4.3

4.4

0.90

0.85

1.49

303

2214

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

140

808

1.73

8.58

1.6

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

355

2545

1.40

8.22

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

119

671

1.77

7.94

1.5

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

334

2391

1.40

7.81

4.3

1.65

1.55

1.37

305

2242

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

582

4537

1.30

7.75

3.5

104.76

97.74

ng/l

0.80

427

3757

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

474

3597

1.33

7.67

3.9

2.9

50.10

56.74

ml/min/173m2

4.84

234

1614

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

523

4035

1.31

7.53

1.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

685

5471

1.27

7.52

2.4

2.5

8.97

10.18

umol/l

0.73

562

4687

(3003458) Phosphate [Moles/volume] in Serum or Plasma

903

7453

1.23

7.40

5.4

4.9

1.04

1.05

mmol/l

0.52

809

6695

(3019060) Gas panel - Arterial blood

516

3984

1.31

7.39

3.6

4.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

114

650

1.75

7.36

1.6

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

302

2.11

7.26

2.1

2.00

2.82

u/field

0.44

204

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

842

6913

1.24

7.25

3.7

3.6

239.43

251.26

u/l

2.46

782

6409

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

106

596

1.77

7.19

1.2

1.5

57.90

65.01

0.88

373

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

6.49

7.04

1.1

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

307

2.08

6.97

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

294

2103

1.40

6.94

2.4

31.07

25.74

au/ml

0.19

(3037756) Immunofixation for Serum or Plasma

211

1420

1.49

6.91

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

715

5800

1.25

6.86

1.8

—

(40768443) Skin Pathology biopsy report

294

2112

1.40

6.78

1.3

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.94

6.67

1.0

1.1

—

(3016502) Oxygen saturation in Arterial blood

750

6147

1.24

6.55

5.4

6.1

95.24

94.99

0.57

705

5891

(3009214) Lutropin [Units/volume] in Serum or Plasma

374

1.92

6.32

1.2

12.30

12.91

u/l

0.13

293

(3042936) Bacteria identified in Isolate by Culture

870

7291

1.21

6.09

1.8

1.9

—

(3012565) Volume of 24 hour Urine

212

2.20

6.03

1.7

2.4

1750.90

1774.95

0.06

172

(3033658) Prothrombin time (PT) actual/Normal

1459

12824

1.16

5.84

3.6

4.0

80.17

81.41

1.06

1414

12508

(3021387) Prolactin [Units/volume] in Serum or Plasma

339

1.91

5.68

1.8

309.88

340.41

mu/l

0.49

311

(3033705) Calcium.ionized [Moles/volume] in Venous blood

948

0.50

5.66

2.3

2.6

—

(3003694) ABO and Rh group [Type] in Blood

1193

10348

1.17

5.63

1.4

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

958

0.50

5.61

2.2

2.6

4.03

4.14

mmol/l

1.23

950

(3051387) C reactive protein [Mass/volume] in Capillary blood

178

1214

1.46

5.53

3.6

4.0

29.93

31.36

mg/l

0.20

133

857

(3017446) Testosterone [Moles/volume] in Serum or Plasma

301

2249

1.34

5.49

1.8

2.0

10.85

10.46

nmol/l

0.28

225

1888

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1075

9272

1.18

5.43

3.4

3.2

3.15

2.60

e6/l

0.62

561

5143

(3003396) Base excess in Arterial blood by calculation

830

7003

1.20

5.40

5.4

5.8

1.20

1.15

mmol/l

0.14

637

5438

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

461

3659

1.27

5.37

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

581

1.66

5.35

1.2

1.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

418

1.79

5.35

1.1

—

u/ml

—

(3003338) MCHC [Mass/volume]

3599

33715

1.13

5.34

28.0

25.9

330.29

329.93

g/l

1.56

3572

33129

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

398

1.80

5.28

1.7

1.8

5.10

4.86

mg/l

0.17

370

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

154

1035

1.49

5.18

1.9

1.6

—

(4035726) Immunohistochemistry procedure

539

4380

1.24

5.11

1.4

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

148

994

1.49

5.01

1.7

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

250

1844

1.36

5.00

1.3

74.65

65.55

au/ml

0.18

101

(3044242) Glucose [Moles/volume] in Arterial blood

365

1.80

4.86

1.8

1.7

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.64

4.80

1.5

1.2

0.34

2.37

mmol/l

1.57

(3019977) pH of Arterial blood

381

1.78

4.80

2.1

2.2

7.41

7.42

0.17

135

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

282

2136

1.32

4.73

3.4

3.0

4.40

4.26

pmol/l

1.38

234

1814

(3017732) Neutrophils [#/volume] in Blood

334

2591

1.29

4.71

3.4

4.41

5.54

e9/l

2.79

209

1855

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

158

1091

1.45

4.67

1.3

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

229

2.00

4.66

1.2

1.4

17.80

2.72

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

655

5494

1.20

4.55

5.9

6.5

117.75

118.28

g/l

0.28

623

5337

(3047007) Chlamydophila sp Ab [Presence] in Serum

280

1.88

4.53

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

123

1790

0.67

4.52

3.9

4.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

818

7011

1.18

4.44

5.5

5.8

11.39

11.65

kpa

0.85

759

6569

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

108

698

1.54

4.42

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

818

7014

1.18

4.42

5.5

5.8

4.98

5.06

kpa

1.86

758

6576

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

152

1056

1.44

4.37

1.5

1.4

0.23

0.24

g/l

0.47

143

984

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.51

4.36

1.3

0.93

0.96

mg/l

0.04

(3017704) Immunofixation for Urine

329

1.78

4.28

1.5

—

(3000492) Spirometry study

379

3027

1.25

4.24

1.5

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

197

2.02

4.21

1.4

41.49

34.93

iu/l

0.55

161

(4062490) Immunoglobulin typing, IgG

304

1.80

4.12

1.6

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

102

2.43

4.12

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

186

1356

1.37

4.08

3.8

2.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

103

2.41

4.04

1.3

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

242

1.89

4.03

1.1

1.2

9.27

9.77

mmol/l

0.38

227

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

580

1.56

4.00

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

129

2.23

3.96

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.57

3.89

1.6

1.2

95.77

501.50

u/l

0.47

(3009445) Proteinase 3 Ab [Units/volume] in Serum

271

2102

1.29

3.88

1.4

1.5

10.48

25.02

u/ml

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

454

1.62

3.83

1.2

1.5

35.37

26.59

0.89

282

(3027135) IgG subclass 1 [Mass/volume] in Serum

304

1.77

3.83

1.6

1.2

5.46

7.23

g/l

2.33

218

(3028192) IgG subclass 2 [Mass/volume] in Serum

304

1.77

3.83

1.6

1.2

2.26

2.99

g/l

2.54

218

(3024139) IgG subclass 3 [Mass/volume] in Serum

304

1.77

3.83

1.6

1.2

0.31

0.50

g/l

3.52

220

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

118

805

1.46

3.79

1.6

4.17

4.21

iu/l

0.02

219

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

151

1082

1.39

3.71

1.5

1.4

1.11

1.15

g/l

0.88

143

1006

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.16

3.71

2.4

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

258

1.81

3.64

1.1

1.2

2.36

2.14

mmol/l

0.32

235

(3011544) Albumin [Mass/volume] in Pleural fluid

2.76

3.61

1.1

1.2

17.72

16.39

g/l

0.33

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

101

675

1.49

3.61

1.4

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

517

1.56

3.58

1.8

1.5

0.56

0.84

g/l

2.24

393

(3020779) Urea [Moles/volume] in Serum or Plasma

626

5355

1.17

3.50

6.0

5.9

12.26

12.07

mmol/l

0.25

576

4989

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

184

1.94

3.47

4.1

4.2

71.93

72.87

0.07

151

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

717

6216

1.16

3.39

3.4

3.7

12.18

26.69

ug/l

2.48

574

5178

(3010838) Calcium [Moles/time] in 24 hour Urine

103

702

1.46

3.37

1.9

1.7

4.25

4.43

mmol/24h

0.23

574

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.04

3.35

1.1

1.2

2790.67

3598.40

ng/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

655

1.47

3.33

2.6

2.2

22.00

30.01

mg/l

0.51

150

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

115

803

1.43

3.31

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

372

1.63

3.29

1.2

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.90

3.25

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.89

3.24

1.6

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

621

1.47

3.18

1.3

1.4

—

(3004775) Volume in Urine collected for unspecified duration

470

1.54

3.15

2.6

2.1

693.33

632.26

0.57

291

(3041918) Cholesterol [Moles/volume] in Pleural fluid

123

2.10

3.11

1.5

1.2

1.73

1.49

mmol/l

0.50

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

195

1497

1.30

3.10

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

158

1180

1.33

3.06

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.23

3.05

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.23

3.05

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.23

3.05

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.23

3.05

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1091

9796

1.12

3.05

3.2

3.0

1.05

1.59

e6/l

1.14

583

5627

(3027456) Digoxin [Moles/volume] in Serum or Plasma

249

1977

1.26

3.03

3.4

3.2

0.78

0.82

nmol/l

1.18

203

1537

(3044290) Cell count panel - Cerebral spinal fluid

637

1.45

3.00

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

221

1734

1.27

2.98

1.1

118.24

133.83

iu/ml

0.20

546

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.52

2.95

1.0

1.1

—

(3021788) Differential panel - Synovial fluid

129

941

1.36

2.92

1.3

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

194

1505

1.29

2.87

2.0

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

360

2991

1.20

2.86

3.3

2.9

0.27

0.36

e6/l

0.86

345

2942

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

6.61

2.84

1.7

1.6

250.22

227.21

nmol/l

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

178

1369

1.30

2.82

1.4

1.5

—

(3008295) Osmolality of Serum or Plasma

508

1.49

2.80

1.4

1.3

273.25

274.45

mosm/kgh2o

0.18

348

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

549

1.47

2.79

1.8

1.9

166.80

2428.64

u/ml

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

180

1389

1.29

2.79

1.4

278.31

258.53

ug/g

0.58

102

870

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

407

3431

1.19

2.76

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

472

1.50

2.70

1.5

—

(40768793) Breast Pathology biopsy report

123

904

1.35

2.69

1.4

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

315

1.61

2.68

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

262

1.67

2.66

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.48

2.64

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

132

1.95

2.62

1.1

1.09

1.06

ratio

—

(3052592) Norovirus Ag [Presence] in Stool

153

1.88

2.62

1.2

1.3

—

(3003181) Sodium [Moles/volume] in Urine

152

1160

1.30

2.58

1.4

1.3

59.85

60.82

mmol/l

0.13

124

913

(3034274) Bile acid [Moles/volume] in Serum --fasting

162

1.84

2.54

1.3

14.88

9.29

umol/l

0.28

105

(40762887) Creatinine [Moles/volume] in Blood

7.08

2.53

1.6

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

555

6235

0.87

2.53

8.0

9.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

299

2475

1.21

2.51

1.5

1.62

1.67

0.46

233

1960

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

200

1.74

2.47

1.5

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

200

1.74

2.47

1.5

2.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

411

1.50

2.42

1.2

2.14

3.91

u/ml

0.82

123

(3044640) Blood type and Crossmatch panel - Blood

1712

15912

1.09

2.38

2.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.30

2.36

1.2

1.3

—

(3017569) Oxygen content in Arterial blood

344

1.53

2.30

2.3

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

363

3084

1.18

2.30

1.5

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

360

1.52

2.30

1.1

124.00

113.74

1.17

307

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

104

2.00

2.30

1.2

1.3

0.13

nmol/l

0.00

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

198

1.70

2.27

1.1

—

(3011985) Renin [Units/volume] in Plasma

516

1.43

2.26

1.3

31.90

53.74

mu/l

1.59

455

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

191

1.71

2.25

1.5

1.2

3.38

1.86

u/ml

0.34

112

(3043410) Blood group antigens tested for on Red Blood Cells

126

1.89

2.24

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

712

1.35

2.20

1.3

1.4

2245.11

1061.22

e6/l

0.33

593

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

712

1.35

2.20

1.2

1.3

39.39

20.05

e6/l

0.25

562

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.13

2.19

1.0

1.5

93.25

80.19

—

(3016038) Potassium [Moles/volume] in Urine

405

1.47

2.18

1.2

1.1

34.18

34.13

mmol/l

0.01

322

(3016018) Differential panel - Cerebral spinal fluid

318

1.53

2.15

1.1

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

548

1.40

2.12

2.0

1.7

28.65

27.54

u/ml

0.07

124

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

482

1.42

2.11

1.2

1.3

263.15

253.72

pmol/l

0.11

402

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.75

2.11

1.0

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

143

1117

1.27

2.10

2.8

2.9

367.45

753.78

u/ml

0.61

123

1026

(3008116) Ketones [Moles/volume] in Urine by Test strip

101

1.96

2.09

1.3

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.08

2.07

1.2

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

102

1.94

2.04

2.0

1.4

1.16

1.20

mmol/l

0.94

(3020911) Cortisol [Moles/time] in 24 hour Urine

102

1.94

2.04

1.6

1.4

74.05

263.86

nmol/24h

0.92

102

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

638

1.36

2.02

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

374

3223

1.16

2.01

2.0

1.6

1.52

1.57

g/l

0.49

295

2736

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

194

1581

1.22

1.98

1.9

1.6

38.22

38.53

u/l

0.07

161

1305

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

131

1021

1.28

1.98

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

605

5391

1.12

1.97

5.1

5.5

1.32

1.43

mmol/l

2.59

584

5192

(3046861) Legionella sp Ag [Presence] in Urine

2.79

1.97

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

230

1.60

1.97

1.1

2.35

16.49

nmol/l

—

(3022621) pH of Urine by Test strip

401

3482

1.15

1.95

3.7

3.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

134

1052

1.27

1.92

1.7

1.5

0.55

12.66

iu/ml

1.32

283

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

287

1.52

1.92

1.2

1.1

91.08

90.60

0.05

256

(3019230) Fractional oxyhemoglobin in Venous blood

117

903

1.29

1.92

2.0

2.2

59.66

60.03

0.06

117

897

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.06

1.91

1.1

1.2

86.00

80.28

—

(3007566) Smooth muscle Ab [Titer] in Serum

118

914

1.28

1.89

1.2

186.15

136.50

titre

0.21

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

519

1.38

1.88

1.1

1.2

48.75

65.33

u/l

3.13

451

(3045414) Leukocytes [Presence] in Urine

237

1982

1.19

1.86

2.4

2.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

2.03

1.86

8.2

9.5

14.14

13.74

0.47

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.98

1.85

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

379

1.44

1.85

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

530

4707

1.13

1.84

2.3

34.68

38.09

u/l

0.84

421

3965

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.54

1.84

10.5

13.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

143

1.73

1.83

1.4

58.25

77.35

umol/l

0.59

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

721

1.31

1.78

3.7

3.6

958.85

4593.48

iu/ml

0.69

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.30

1.73

1.0

1.2

520.83

258.78

nmol/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

380

3324

1.14

1.70

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

170

1392

1.22

1.70

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.64

1.70

1.0

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

260

2215

1.17

1.67

2.7

2.3

1.29

1.10

g/l

0.22

194

1834

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

297

1.47

1.67

1.1

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

225

1.54

1.66

1.1

—

(3006462) Nitrate [Presence] in Urine

249

1.51

1.66

6.7

3.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.98

1.65

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.93

1.65

1.3

2.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

168

1382

1.21

1.62

2.5

2.1

110.72

90.00

ug/min

0.31

103

791

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

251

1.50

1.61

2.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

726

0.72

1.60

1.3

0.98

0.81

nmol/l

0.42

584

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.23

1.60

2.0

1.6

—

(3016330) Potassium [Moles/time] in 24 hour Urine

2.31

1.57

1.1

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

242

2063

1.17

1.57

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

520

1.34

1.56

1.6

1.4

14.78

13.69

u/l

0.64

503

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

166

1.61

1.55

2.3

1.9

1211.70

1681.91

u/ml

0.54

159

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

113

1.76

1.55

1.3

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

444

1.36

1.55

1.3

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.98

1.55

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.93

1.55

1.4

1.2

—

(1002224) Polysomnography panel

642

1.30

1.54

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

238

1.50

1.53

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

437

1.36

1.52

2.9

3.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

574

1.31

1.52

1.4

1.3

13.05

13.66

u/l

0.11

527

(3024928) Oxygen saturation in Venous blood

151

1239

1.21

1.51

2.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

219

1862

1.17

1.48

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

248

1.48

1.6

1.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

296

2575

1.15

1.47

2.3

2.2

3.69

3.74

g/l

0.15

246

2251

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

314

1.42

1.47

2.2

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

595

1.30

1.47

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

271

3064

0.87

1.46

3.6

3.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.88

1.45

3.1

3.0

0.33

0.53

u/field

0.53

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

399

1.37

1.45

1.2

2.55

3.97

u/ml

1.44

186

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

112

896

1.24

1.44

1.2

1.3

68.30

38.79

u/l

0.51

766

(3024354) Oxygen [Partial pressure] in Venous blood

453

4958

0.90

1.44

2.5

2.9

4.35

kpa

0.01

436

4753

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

240

2061

1.16

1.44

2.4

2.1

37.02

36.51

g/l

0.70

189

1723

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

296

2582

1.14

1.43

2.3

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

296

2584

1.14

1.41

2.3

2.2

7.42

7.63

g/l

1.41

245

2254

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.10

1.41

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

132

1.65

1.41

1.7

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

573

1.30

1.41

2.4

2.5

2.41

2.19

u/field

0.08

180

(3035880) pH of Pleural fluid

436

1.34

1.39

1.4

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.15

1.36

1.0

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

277

3108

0.88

1.35

2.9

3.3

25.11

25.14

mmol/l

0.06

257

3023

(1617658) Protocol used for examination of sentinel lymph nodes

320

1.40

1.35

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

111

1.70

1.34

2.1

1.4

1.16

1.18

mmol/l

0.67

106

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

329

1.39

1.33

1.3

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

206

1.49

1.32

5.5

5.8

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

449

1.33

1.32

1.5

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

449

1.33

1.32

1.5

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

253

2198

1.15

1.32

1.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

336

2975

1.12

1.31

1.5

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

129

1061

1.21

1.30

1.8

2.1

200.34

217.82

1.42

117

986

(3045142) Bone marrow Pathology biopsy report

563

1.29

1.30

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

634

1.27

1.28

1.3

1.2

30.13

49.32

u/ml

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

280

2454

1.14

1.28

2.3

2.2

10.21

10.40

g/l

0.25

229

2101

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

332

1.37

1.28

2.4

2.2

107.44

86.79

ug/min

—

(40768441) Liver Pathology biopsy report

257

1.43

1.27

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

645

1.26

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

135

1120

1.20

1.26

1.7

2.0

89.93

87.69

0.61

124

1071

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.27

1.26

7.0

3.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

454

0.70

1.24

1.0

1.1

1.17

1042.14

iu/ml

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.06

1.24

1.1

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

193

1.49

1.24

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

193

1.49

1.24

1.3

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

161

1.54

1.23

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

115

942

1.21

1.23

1.2

1.1

1201.43

1114.58

titre

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.38

1.23

1.5

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

2398

1.13

1.22

2.3

2.94

3.10

g/l

1.93

223

2068

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

150

1260

1.18

1.22

1.5

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

464

1.30

1.22

1.3

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

140

0.49

1.20

1.1

1.2

14.66

14.94

g/l

—

107

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.02

1.19

1.0

1.1

—

(44813793) Dust mix specific IgE antibody measurement

155

1.54

1.18

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

221

1.44

1.15

1.5

1.2

1.26

1.15

nmol/l

0.19

162

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

141

1186

1.18

1.15

1.9

2.1

3.62

3.66

g/l

0.14

132

1119

(3044941) Cell count panel - Synovial fluid

104

851

1.21

1.14

1.3

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

1.76

1.13

27.8

29.1

6.01

6.82

ug/l

0.91

(4200892) Spirometry reversibility

327

2921

1.11

1.13

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

141

1.55

1.12

1.1

1.3

43.54

28.94

0.67

(3028308) Erythrocytes [#/volume] in Pleural fluid

945

0.80

1.12

1.4

77841.59

57127.88

e6/l

0.16

556

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

190

1641

1.15

1.12

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

190

1641

1.15

1.12

1.4

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

497

1.28

1.11

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

269

2378

1.13

1.11

2.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

142

1.54

1.10

1.7

1.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.24

1.09

6.7

4.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

240

2111

1.13

1.08

2.0

2.2

512.76

651.06

ug/l

0.46

223

1994

(40768446) Kidney Pathology biopsy report

111

1.61

1.08

1.6

1.4

—

(3022689) Creatine [Moles/volume] in Urine

1.69

1.07

1.1

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.69

1.07

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

119

1.58

1.07

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

687

1.23

1.07

1.5

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

687

1.23

1.07

1.5

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

110

913

1.20

1.06

4.2

3.6

0.99

1.54

1.74

774

(4094501) Cardiovascular stress test using bicycle ergometer

120

1005

1.19

1.05

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

433

1.28

1.03

1.3

1.4

—

(3002032) Base excess in Venous blood by calculation

564

5995

0.93

1.02

3.2

3.5

1.71

1.99

mmol/l

1.12

471

5006

(3002079) Sodium [Moles/time] in 24 hour Urine

145

1.50

1.01

1.1

1.2

135.32

145.85

mmol/24h

0.36

145

(3001019) Free T4 and TSH panel - Serum or Plasma

382

1.30

1.01

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

452

1.27

1.01

1.2

1.1

284.15

302.54

u/ml

0.17

267

(3006270) Folate [Moles/volume] in Blood

532

1.25

1.00

1.3

1.2

296.13

329.61

nmol/l

0.80

399

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

374

1.30

1.00

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

130

0.53

0.98

1.1

2.9

—

39.09

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

323

1.32

0.98

1.1

83.75

143.33

titre

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

323

1.32

0.98

1.1

—

120.71

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.82

0.97

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

437

1.27

0.97

1.3

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

490

1.26

0.97

1.4

1.3

122.35

120.29

u/ml

0.05

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.93

0.96

1.0

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

172

1.44

0.95

1.4

1.3

18.70

22.82

0.39

136

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.65

0.94

1.1

—

(21494434) Karyotype in Bone marrow

475

1.25

0.93

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.87

0.93

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

485

1.25

0.92

1.2

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

224

1.37

0.91

1.3

1.2

1.24

0.93

promille

0.55

167

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

530

1.24

0.91

1.1

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

477

1.25

0.91

1.5

1.3

201.00

376.90

titre

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.60

0.90

6.9

8.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

640

1.21

0.89

1.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.05

0.88

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.89

0.88

1.4

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

312

1.30

0.88

1.3

1.5

12.75

6.16

u/l

1.06

242

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

167

1.42

0.88

3.2

2.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

578

1.22

0.87

1.4

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

1.84

0.86

1.1

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

176

1.41

0.86

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

176

1.41

0.86

1.2

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

340

1.28

0.85

8.9

13.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

653

1.20

0.84

3.4

3.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

570

6006

0.93

0.84

3.2

3.4

5.82

5.85

kpa

0.29

548

5790

(3036525) Urea [Moles/time] in 24 hour Urine

1.92

0.83

2.7

3.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.76

0.83

1.0

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

128

1.47

0.82

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

466

1.23

0.82

1.3

—

nmol/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

138

1201

1.14

0.80

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

486

1.22

0.79

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

183

1623

1.12

0.79

1.6

90.91

285.19

titre

2.38

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

146

1.43

0.79

1.1

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

505

1.22

0.78

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.80

0.78

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.80

0.78

1.2

1.3

—

(3025577) Chromium [Mass/volume] in Blood

398

1.25

0.78

2.0

1.9

2.44

2.10

ug/l

0.34

334

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

206

1.35

0.77

1.3

1.1

0.36

0.78

u/ml

1.07

103

(3012441) Differential panel - Pleural fluid

902

0.84

0.77

1.3

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

147

1.42

0.76

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.52

0.75

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.54

0.75

1.0

80.43

92.57

—

(3052851) Hemolysis interference index of Serum or Plasma

211

1894

1.11

0.74

3.2

3.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

107

1.48

0.73

1.1

—

7.50

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

747

1.17

0.73

1.3

1.2

15.67

4.14

u/ml

0.67

(3023183) Ammonium ion [Moles/volume] in Plasma

116

1006

1.14

0.72

1.8

2.0

28.31

32.67

umol/l

1.69

848

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.50

0.72

1.0

4.80

0.71

u/ml

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.50

0.72

1.0

1.1

0.61

0.63

umol/24h

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

132

1.43

0.72

1.7

1.4

10.06

8.45

ug/l

0.23

117

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1.52

0.72

1.0

0.91

0.71

u/ml

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.98

0.72

2.2

1.6

19.98

15.08

umol/l

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

101

869

1.15

0.71

1.3

1.2

25.73

3.78

u/ml

0.52

(3022493) Free Hemoglobin [Mass/volume] in Plasma

227

1.31

0.70

1.2

3.4

58.62

64.35

mg/l

0.24

161

(3006922) Hepatitis E virus Ab [Presence] in Serum

193

1.34

0.69

1.2

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.56

0.69

7.3

8.9

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

298

1.26

0.69

1.1

—

4.10

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

273

1.27

0.67

5.3

4.8

219.03

134.35

u/ml

0.23

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

543

1.19

0.66

1.2

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

462

1.20

0.65

1.6

1.3

72.00

53.33

titre

—

(3039443) Prostate specific Ag panel - Serum or Plasma

369

0.78

0.65

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

101

877

1.14

0.64

1.3

1.2

5.51

5.46

u/ml

0.01

122

(3006653) Thiamine [Moles/volume] in Blood

187

1.33

0.64

1.1

128.32

132.45

nmol/l

0.24

187

(3020393) Adenovirus Ag [Presence] in Stool

1.58

0.64

1.1

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

455

1.20

0.63

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

214

1943

1.09

0.63

2.6

2.2

0.02

0.05

g/l

1.40

182

1731

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.71

0.63

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

111

1.43

0.63

1.6

2.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

162

1.35

0.63

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

1019

0.87

0.62

1.4

1.5

1270.89

1783.20

e6/l

0.84

709

(3035637) Corticotropin [Mass/volume] in Plasma

456

1.20

0.62

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

348

1.23

0.61

1.3

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

567

1.17

0.61

1.4

1.2

—

22.67

—

(3019832) Treponema pallidum Ab [Presence] in Serum

798

1.14

0.61

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.65

0.60

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

313

1.24

0.60

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

106

929

1.13

0.60

1.3

1.2

73.83

51.78

u/ml

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

548

5701

0.95

0.59

2.2

2.4

5.20

6.44

ug/l

2.06

427

4729

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.50

0.57

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

114

0.61

0.57

1.4

1.2

—

(40761535) Cells panel - Urine sediment

422

4418

0.94

0.57

3.1

3.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

203

1851

1.09

0.56

2.6

2.2

0.00

g/l

0.34

174

1645

(3020876) Protein [Mass/time] in 24 hour Urine

655

1.15

0.56

2.3

1.09

1.06

g/24h

0.03

300

(3036782) Glucose [Moles/volume] in Pleural fluid

730

1.14

0.55

1.4

6.50

6.41

mmol/l

0.10

672

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

317

1.22

0.55

1.2

8.70

7.94

mmol/l

0.58

252

(21494815) CD4 cells/100 lymphocytes in Specimen

264

1.24

0.54

1.6

1.8

39.85

37.07

0.30

255

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

167

1.31

0.53

1.1

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

176

1.30

0.53

2.6

2.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

124

1.36

0.53

1.0

0.12

0.33

u/ml

0.66

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

540

0.84

0.53

1.7

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

107

1.39

0.53

1.3

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.52

0.52

1.0

1.1

1.63

1.71

umol/24h

—

(40765096) Chromosome analysis panel by Banding

133

0.67

0.51

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.60

0.51

1.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

290

0.78

0.51

1.0

1.3

—

1588.57

—

(3024263) Appearance of Synovial fluid

289

0.79

0.50

1.7

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

258

1.23

0.50

1.2

1.1

—

3.20

iu/ml

—

(3044927) Protein electrophoresis panel - Urine

663

1.14

0.49

1.1

1.2

—

(3037121) Protein [Mass/volume] in Urine

197

1809

1.08

0.49

2.9

2.7

0.28

0.30

g/l

0.13

693

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

198

1820

1.08

0.48

2.6

2.2

0.00

g/l

-0.00

174

1639

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.40

0.48

1.2

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

525

1.15

0.48

2.1

3.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.48

0.47

1.1

1.4

1.53

2.35

umol/l

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

153

1.30

0.47

1.0

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.48

0.47

1.0

1.2

—

80.20

—

(3042733) HLA Ab [Presence] in Serum

1.44

0.46

3.4

4.5

—

(21494755) Public health laboratory ask at order entry panel

392

0.83

0.45

1.8

1.4

—

(3023410) Appearance of Cerebral spinal fluid

316

0.81

0.44

1.2

1.3

—

(3036489) Thrombin time

173

1589

1.08

0.44

1.5

1.8

21.55

22.03

0.84

151

1441

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

164

1.27

0.43

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.42

0.43

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

227

1.22

0.43

1.3

166.02

314.22

ug/l

0.31

127

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

1.35

0.43

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

811

0.89

0.43

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

130

0.69

0.43

1.8

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

111

1002

1.10

0.42

2.0

1.7

12.29

12.40

mg/l

0.04

100

909

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.42

0.42

6.5

7.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

570

1.13

0.41

1.4

1.2

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.41

0.0

1.1

—

379.60

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.41

0.0

1.6

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.01

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

860

0.90

0.41

1.7

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

532

5473

0.96

0.40

4.8

35.34

34.04

1.59

264

3399

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.05

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.40

0.0

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.2

—

350.82

—

(4281824) Cell count and differential, peritoneal fluid

514

0.87

0.40

1.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.46

0.40

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.40

0.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.32

0.39

1.0

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.34

0.39

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.34

0.39

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.34

0.39

1.0

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

294

1.18

0.39

1.2

1.5

72.17

66.70

0.44

231

(3016879) Cocaine [Presence] in Urine

111

0.71

0.37

1.4

1.2

—

(3027944) Amphetamines [Presence] in Urine

112

0.71

0.37

1.4

1.2

—

(3027008) Opiates [Presence] in Urine

114

0.69

0.37

1.4

1.2

—

(3028300) Cannabinoids [Presence] in Urine

115

0.69

0.36

1.4

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

708

1.11

0.36

5.0

5.8

11.90

12.66

mg/l

0.81

626

(3008898) HLA-B27 [Presence]

548

1.12

0.36

1.0

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

133

1.27

0.36

1.4

1.6

3.00

7.06

1.36

(3048879) Bone marrow aspiration report

178

1.22

0.36

1.2

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

275

0.83

0.36

8.3

3.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.45

0.36

1.3

1.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.45

0.36

1.2

13.00

10.93

u/l

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

210

1965

1.06

0.35

4.0

4.2

24.64

24.94

mmol/l

0.68

179

1746

(42529406) Shigella sp [Presence] in Stool by Culture

128

1364

0.93

0.35

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

125

0.71

0.35

1.2

—

(3014891) Appearance of Pleural fluid

152

1.24

0.34

1.4

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

128

1362

0.93

0.34

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

171

1.22

0.33

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

117

1.27

0.33

1.3

140.00

151.93

nmol/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.70

0.33

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.29

0.32

1.0

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

319

1.15

0.32

1.1

1.2

77.72

100.42

u/l

1.28

270

(3011397) Hemoglobin [Presence] in Urine by Test strip

1181

11467

1.02

0.31

3.9

4.1

—

(40768795) Lymph node Pathology biopsy report

442

1.12

0.31

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.34

0.30

1.6

1.7

9.96

9.75

ug/l

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.71

0.30

3.0

2.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

443

1.12

0.30

1.1

1.46

1.60

g/l

2.08

398

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.28

0.30

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

312

1.14

0.30

1.1

1.2

20.33

29.53

u/l

0.97

255

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.26

0.29

1.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

318

3028

1.04

0.29

3.4

3.6

24.15

24.14

mmol/l

0.01

310

2913

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

106

0.75

0.29

2.5

1.3

120.57

150.94

pmol/l

—

106

(3020491) Glucose [Moles/volume] in Blood

331

0.87

0.28

2.2

2.6

6.96

7.18

mmol/l

0.28

239

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

128

1350

0.94

0.28

1.2

—

(3012544) pH of Venous blood

605

6153

0.97

0.28

3.1

3.5

7.36

7.38

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

160

0.80

0.27

1.9

2.0

57.28

53.15

umol/l

—

126

(3015183) Erythrocyte sedimentation rate

1.26

0.27

1.4

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

117

1087

1.07

0.27

1.4

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

183

1904

0.95

0.27

3.2

4.1

105.02

89.58

u/ml

0.13

170

1808

(3002523) Influenza virus A Ag [Presence] in Specimen

158

1.19

0.26

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

150

1.19

0.24

1.1

1.2

—

(3022313) Gas panel - Capillary blood

255

2431

1.04

0.24

3.6

3.9

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

132

1.20

0.23

1.3

1.1

—

(3051651) Icteric interference index of Serum or Plasma

356

0.89

0.23

3.6

3.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

283

0.87

0.23

1.0

1.1

6.90

2.68

u/ml

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

114

1.22

0.23

1.1

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

134

1259

1.06

0.23

1.5

15388.79

16257.38

e6/l

0.09

886

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

151

1.18

0.23

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.27

0.22

1.6

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.24

0.22

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

161

1.17

0.22

1.1

—

(40757373) Influenza virus identified in Isolate

152

1.17

0.21

1.3

—

(36303858) Crystals [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

8.73

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

4.9

—

340.80

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

2340.91

—

(3000991) Gas panel - Venous blood

505

5121

0.97

0.21

6.4

6.5

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.18

0.21

2.8

1.90

1.13

mg/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

598

1.08

0.21

1.2

1.4

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.1

—

1.23

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.21

0.0

1.3

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

3.58

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.21

0.0

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

171

1.16

0.21

1.1

46.09

39.51

g/l

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.25

0.21

1.2

1.3

11.44

7.39

mg/l

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

125

1.19

0.20

1.5

0.28

0.34

ug/l

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

196

0.86

0.20

2.1

2.6

41.58

35.96

0.59

114

(3009466) Valproate [Moles/volume] in Serum or Plasma

561

1.08

0.20

4.1

3.5

326.45

320.87

umol/l

0.10

447

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

294

1.11

0.20

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.20

0.0

1.5

—

(40763791) Oxygen content in Venous blood by calculation

0.00

0.20

0.0

2.3

—

12.24

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.20

0.0

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.20

0.0

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

147

1522

0.96

0.20

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.24

0.20

1.2

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

206

0.87

0.20

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.21

0.20

1.0

1.3

—

80.53

—

(3034426) Prothrombin time (PT)

1.22

0.19

1.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

173

1.15

0.19

1.1

1.0

0.36

1.65

u/ml

—

(3047189) Immunofixation for 24 hour Urine

287

1.10

0.18

1.4

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.20

0.18

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

440

1.08

0.18

1.2

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

266

0.89

0.17

1.1

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

827

1.05

0.17

1.2

—

(4146454) Self-monitoring of blood glucose

576

1.07

0.17

2.5

2.7

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.76

0.17

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

528

1.07

0.17

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

298

1.10

0.17

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

298

1.10

0.17

1.3

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.73

0.17

1.6

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.72

0.16

1.6

2.2

—

(37021550) Renin [Units/volume] in Plasma --upright

100

1.19

0.16

1.4

1.3

32.42

71.45

mu/l

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

597

1.06

0.16

1.3

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

305

0.91

0.16

1.8

2.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

607

1.06

0.16

1.2

1.4

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

138

1.15

0.15

1.4

1.6

97.20

121.55

ug/l

—

115

(3004616) Nuclear Ab [Presence] in Serum

448

0.93

0.15

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

0.79

0.15

1.5

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

110

1.17

0.15

1.2

1.1

339.33

237.20

pmol/l

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

176

1.13

0.15

1.1

1.0

0.34

1.33

u/ml

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

129

1.15

0.15

1.3

18.89

16.67

pmol/l

—

(3013727) Leukocytes other/100 leukocytes in Blood

201

0.89

0.15

9.3

3.4

48.36

55.24

0.45

193

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.13

0.15

1.0

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

599

1.06

0.15

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

599

1.06

0.15

1.2

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.81

0.14

1.0

1.4

1.50

1.54

g/l

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

619

1.06

0.14

1.2

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

200

0.89

0.14

1.0

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

130

1.14

0.14

1.1

—

495.95

—

(3000093) Morphology [Interpretation] in Blood Narrative

572

1.06

0.13

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.81

0.13

1.4

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

789

0.95

0.13

1.5

1.8

17.93

24.60

ug/l

1.40

763

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

131

1.13

0.12

1.6

1.7

—

(40758558) Short blood count panel - Blood

1223

12004

1.01

0.12

5.8

6.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

188

0.90

0.12

1.2

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

544

0.95

0.12

3.7

3.6

52.93

58.23

0.73

430

(3033799) Differential panel - Peritoneal fluid

177

0.90

0.12

1.3

1.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.17

0.11

12.5

13.4

5.02

5.11

mmol/l

—

(3019225) pH of Specimen

533

5212

1.01

0.10

4.0

4.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

364

3662

0.98

0.10

2.6

3.1

124.87

125.71

g/l

0.32

348

3583

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.15

0.10

1.7

1.4

98.45

127.85

ng/l

0.57

(3008757) Leukocyte morphology finding [Identifier] in Blood

560

0.95

0.10

5.8

4.2

—

(3000034) Microalbumin [Mass/volume] in Urine

414

1.05

0.09

2.9

3.1

73.88

36.40

mg/l

0.57

308

(3025130) Human papilloma virus identified in Specimen

215

0.92

0.09

1.5

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

265

0.93

0.08

1.1

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

112

0.88

0.08

1.2

1.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

340

3322

1.01

0.08

7.0

7.2

24.42

24.39

mmol/l

0.06

319

3114

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.02

0.08

1.0

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

387

1.05

0.08

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

387

1.05

0.08

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

387

1.05

0.08

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

122

0.89

0.08

1.6

1.3

27.00

29.41

umol/l

0.41

116

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.05

0.08

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.85

0.07

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.85

0.07

8.7

4.7

36.00

70.38

u/l

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.85

0.07

1.3

1.5

44.33

43.90

umol/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.02

0.07

1.0

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

117

1133

1.02

0.07

1.4

1.5

31.19

30.73

g/l

0.14

101

987

(3024869) Neuronal Ab [Presence] in Serum

1.07

0.07

1.3

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

156

1.08

0.06

2.1

1.7

—

(3051611) Lipemic interference index of Serum or Plasma

663

0.97

0.06

3.6

3.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

439

1.04

0.06

1.4

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

166

1.07

0.06

1.2

1.7

7262.83

23492.60

e6/l

—

(3020891) Body temperature

236

2307

1.01

0.06

3.7

4.3

—

(3028433) Virus identified in Specimen by Culture

137

1.08

0.06

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

108

1.10

0.06

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

261

0.95

0.05

1.3

1.8

107.76

99.63

umol/l

0.18

261

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

150

0.92

0.05

2.4

1.9

22.08

59.30

u/l

1.30

139

(40759836) Histone Ab [Presence] in Serum by Immunoblot

245

1.05

0.05

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

245

1.05

0.05

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

210

0.94

0.05

1.1

—

(3045788) Cell count panel - Pleural fluid

795

1.02

0.05

1.4

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

412

1.03

0.05

1.4

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

481

1.03

0.04

1.1

1.3

308746.64

179409.68

e6/l

0.29

319

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

246

1.05

0.04

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

246

1.05

0.04

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

246

1.05

0.04

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.10

0.04

1.5

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

305

1.04

0.04

1.1

1.0

295.00

327.48

ng/l

0.33

186

(3029075) Extractable nuclear Ab panel - Serum

100

1.09

0.04

1.2

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

227

1.05

0.04

1.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

214

2140

0.99

0.04

2.7

3.6

1.43

1.45

mmol/l

0.09

209

2102

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

247

1.04

0.04

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

306

1.04

0.03

1.1

1.0

33.86

45.67

ng/l

1.34

185

(40768806) Pleura Pathology biopsy report

876

0.98

0.03

1.5

1.6

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

130

1.07

0.03

2.3

2.5

6.43

7.86

mmol/l

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

238

1.04

0.03

1.4

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

238

1.04

0.03

1.4

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

307

1.03

0.03

1.1

1.0

703.90

641.04

ng/l

0.27

180

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

376

1.03

0.03

1.3

1.2

1.77

1.44

nmol/l

0.84

329

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

209

1.04

0.03

1.0

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

326

0.97

0.02

1.2

1.1

—

71.69

—

(3044007) Cell count panel - Peritoneal fluid

151

1.05

0.02

1.3

1.8

—

(4034850) Laboratory test

147

1467

0.99

0.02

9.5

12.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

633

0.99

0.02

1.9

1.6

1.97

3.40

mg/l

0.94

490

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

310

1.02

0.01

2.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

182

1.03

0.01

1.2

1.9

665.40

4212.46

e6/l

—

125

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

234

0.97

0.01

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

133

1.04

0.00

1.1

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1216

12050

1.00

0.00

2.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

183

1.03

0.00

1.5

1.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

189

1.00

0.00

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

197

1.01

0.00

2.0

2.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

212

2097

1.00

0.00

3.1

3.0

3415.38

3505.30

u/ml

0.01

189

1759

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

182

0.98

0.00

1.6

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

182

0.98

0.00

1.6

1.7

—

(3003129) Base excess in Capillary blood by calculation

131

0.98

0.00

1.8

1.9

-0.46

0.98

mmol/l

0.86

118

(3002619) Bacteria identified in Specimen by Culture

122

0.97

0.00

1.3

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

255

2526

1.00

0.00

2.6

0.35

u/ml

0.08

144

1421

(3020650) Glucose [Presence] in Urine

1.03

0.00

1.7

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

323

1.01

0.00

1.4

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

323

1.01

0.00

1.4

1.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.7

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.93

-0.00

1.1

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.25

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

3120.00

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

0.20

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.0

—

(3005033) Fetal Nuchal fold Thickness US

0.00

-0.00

0.0

1.2

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.7

—

1.80

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.8

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.6

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(3011288) Drugs identified in Urine by Screen method

0.90

-0.00

1.4

1.5

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.8

—

2.80

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

1.54

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

8.8

—

93.80

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.4

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

-0.00

0.0

1.5

—

13.74

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_HL_PRESBY and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_HL_PRESBY	0.901 [0.83, 0.98]	0.013
Birth year	0.994 [0.99, 1.0]	0.113

During the follow-up period (1.1.1998 — 31.12.2019), 17982 out of 34767 females with H8_HL_PRESBY died.

Males

Parameter	HR [95% CI]	p-value
H8_HL_PRESBY	0.939 [0.85, 1.03]	0.19
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 12373 out of 23536 males with H8_HL_PRESBY died.

Mortality risk

Mortality risk for people of age

years, who have H8_HL_PRESBY.

N-year risk	Females	Males
1	0.082%	0.164%
5	0.533%	1.051%
10	1.268%	2.716%
15	2.457%	5.224%
20	4.262%	8.789%

Relationships between endpoints

↥

Index endpoint: H8_HL_PRESBY – Presbycusis

GWS hits: 7

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Presbycusis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints